<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27764091</article-id><article-id pub-id-type="pmc">5072630</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0160305</article-id><article-id pub-id-type="publisher-id">PONE-D-15-47351</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Physical Activity</subject><subj-group><subject>Physical Fitness</subject><subj-group><subject>Exercise</subject><subj-group><subject>Strength Training</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Sports and Exercise Medicine</subject><subj-group><subject>Exercise</subject><subj-group><subject>Strength Training</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Sports Science</subject><subj-group><subject>Sports and Exercise Medicine</subject><subj-group><subject>Exercise</subject><subj-group><subject>Strength Training</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal System</subject><subj-group><subject>Limbs (Anatomy)</subject><subj-group><subject>Legs</subject><subj-group><subject>Knees</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal System</subject><subj-group><subject>Limbs (Anatomy)</subject><subj-group><subject>Legs</subject><subj-group><subject>Knees</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Heart Rate</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Vascular Medicine</subject><subj-group><subject>Blood Pressure</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal System</subject><subj-group><subject>Limbs (Anatomy)</subject><subj-group><subject>Arms</subject><subj-group><subject>Elbow</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal System</subject><subj-group><subject>Limbs (Anatomy)</subject><subj-group><subject>Arms</subject><subj-group><subject>Elbow</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Biomarkers</subject><subj-group><subject>Creatinine</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Oxidative Stress</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Pomegranate Supplementation Accelerates Recovery of Muscle Damage and Soreness and Inflammatory Markers after a Weightlifting Training Session</article-title><alt-title alt-title-type="running-head">Pomegranate and Biological Recovery in Weightlifting</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ammar</surname><given-names>Achraf</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Turki</surname><given-names>Mouna</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chtourou</surname><given-names>Hamdi</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hammouda</surname><given-names>Omar</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Trabelsi</surname><given-names>Khaled</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kallel</surname><given-names>Choumous</given-names></name><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Abdelkarim</surname><given-names>Osama</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hoekelmann</surname><given-names>Anita</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bouaziz</surname><given-names>Mohamed</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref><xref ref-type="aff" rid="aff009"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ayadi</surname><given-names>Fatma</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Driss</surname><given-names>Tarak</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Souissi</surname><given-names>Nizar</given-names></name><xref ref-type="aff" rid="aff010"><sup>10</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Research Unit: Education, Motricit&#x000e9;, Sport et Sant&#x000e9;, UR15JS01, High Institute of Sport and Physical Education of Sfax, University of Sfax, Sfax, Tunisia</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Institute of Sport Science, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Laboratory of Biochemistry, CHU Habib Bourguiba, Sfax University, Sfax, Tunisia</addr-line></aff><aff id="aff004"><label>4</label><addr-line>High Institute of Sport and Physical Education, Sfax University, Sfax, Tunisia</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Research Center on Sport and Movement (EA 2931), University of Paris Ouest La Defense, Nanterre, France</addr-line></aff><aff id="aff006"><label>6</label><addr-line>Laboratory of Pharmacology, Faculty of Medicine, Sfax University, Sfax, Tunisia</addr-line></aff><aff id="aff007"><label>7</label><addr-line>Laboratory of Hematology, CHU Habib Bourguiba, Sfax, Tunisia</addr-line></aff><aff id="aff008"><label>8</label><addr-line>Electrochemistry and Environment Laboratory, ENIS, Sfax University, Sfax, Tunisia</addr-line></aff><aff id="aff009"><label>9</label><addr-line>High Institute of Biotechnology, Sfax University, Sfax, Tunisia</addr-line></aff><aff id="aff010"><label>10</label><addr-line>National Observatory of Sport, Tunis, Tunisia</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Fisher</surname><given-names>Gordon</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Alabama at Birmingham, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> AA HC KT OH.</p></list-item><list-item><p><bold>Data curation:</bold> AA MT HC CK OA MB FA.</p></list-item><list-item><p><bold>Formal analysis:</bold> AA HC CK MB FA.</p></list-item><list-item><p><bold>Investigation:</bold> AA MT HC KT NS.</p></list-item><list-item><p><bold>Methodology:</bold> AA MT HC KT.</p></list-item><list-item><p><bold>Project administration:</bold> AA.</p></list-item><list-item><p><bold>Supervision:</bold> NS.</p></list-item><list-item><p><bold>Validation:</bold> OH AHTD NS.</p></list-item><list-item><p><bold>Visualization:</bold> AA MTHC OH.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> AA.</p></list-item><list-item><p><bold>Writing &#x02013; review &#x00026; editing:</bold> MT HC OH KT TD NS AH.</p></list-item></list></p></fn><corresp id="cor001">* E-mail: <email>ammar.achraf@ymail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>10</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>10</issue><elocation-id>e0160305</elocation-id><history><date date-type="received"><day>1</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>18</day><month>7</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Ammar et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Ammar et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0160305.pdf"/><abstract><sec id="sec001"><title>Purpose</title><p>The aim of this study was to investigate the effect of natural Pomegranate juice supplementation on performance and acute and delayed responses of muscle soreness and biomarkers of muscle damage after a weightlifting training session.</p></sec><sec id="sec002"><title>Methods</title><p>Nine elite weightlifters (21&#x000b1;0.5 years) performed two Olympic-Weightlifting-sessions after either placebo (PLA) or natural pomegranate juice (POMj) supplementations. Heart rate, blood pressure and blood samples (hematological parameters, muscle damage and C-reactive protein (CRP)) were collected at rest, 3min and 48h after each session. Weightlifting performance, RPE, and DOMS were also assessed after each training session.</p></sec><sec id="sec003"><title>Results</title><p>T-test showed higher performance (+8.30%) and lower RPE values (-4.37%) using POMj supplementation (p&#x0003c;0.05) in comparison with PLA. For the DOMS values, a significant improvement (13.4%) was shown only for the knee extensors (p&#x0003c;0.01) using the POMj. Compared to PLA condition, POMj attenuated the acute (i.e., 3min) increase of systolic blood pressure (SBP), HR, CK and LDH (p&#x0003c;0.05; -4.46%, -1.81%, -8.75%, -1.64%, respectively) and blunted the significant increase of ASAT, PAL and CRP (p&#x0003e;0.05). Additionally, during the 48h following the training session, POMj improved the recovery kinetic of SBP (p&#x0003c;0.01, 7.97%), CK (p&#x0003c;0.001, 11.34%), LDH (p&#x0003c;0.05, 7.30%) and ASAT (p&#x0003c;0.05, 6.77%). Indeed, the present study showed that 48h of recovery associated to natural POMj supplementation was sufficient to reach the resting values of the selected muscle damage markers after intensive training session.</p></sec><sec id="sec004"><title>Conclusion</title><p>Natural POMj seems to ameliorate the capacity to adhere to an intensive training program. Therefore, elite weightlifters are advised to use natural POMj during intensive training program and competition to accelerate muscle recovery.</p></sec><sec id="sec005"><title>Trial Registration</title><p>ClinicalTrials.gov <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02697903">NCT02697903</ext-link></p></sec></abstract><funding-group><funding-statement>The author(s) received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="3"/><page-count count="19"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec006"><title>Introduction</title><p>Exhaustive or unaccustomed intense exercise can decrease maximal strength [<xref rid="pone.0160305.ref001" ref-type="bibr">1</xref>], and increase muscle damage, oxidative stress, inflammation, which may decrease the ability to exercise and adhere to a training program [<xref rid="pone.0160305.ref002" ref-type="bibr">2</xref>]. Additionally, intense exercise is often followed by a period of weakness and soreness that can last for days or weeks with peak generally happening between 24 and 48h following exercise [<xref rid="pone.0160305.ref003" ref-type="bibr">3</xref>]. Olympic weightlifting exercises, well known as a very intense common type of strength training, are among the exercises concerned by these problems [<xref rid="pone.0160305.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0160305.ref005" ref-type="bibr">5</xref>]. In this context, and according to Lui et al. [<xref rid="pone.0160305.ref004" ref-type="bibr">4</xref>] and Pettersson. [<xref rid="pone.0160305.ref005" ref-type="bibr">5</xref>], both long-term exercise training and one week of intensive resistance training increased oxidative stress, muscle damage and cell injury in elite weightlifters. Therefore, appropriate rest after intensive training was found to be important for recovery. Recently, Ammar et al. [<xref rid="pone.0160305.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0160305.ref007" ref-type="bibr">7</xref>] demonstrated that markers of muscle damage, oxidative stress and inflammation increased immediately after an Olympic-weightlifting session with higher rates of increase in the morning compared to the evening and afternoon sessions. They have shown also that 48h are not enough to recover the rest values for the majorities of these parameters (i.e., especially after the morning session) [<xref rid="pone.0160305.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0160305.ref007" ref-type="bibr">7</xref>].</p><p>On the other hand, accumulating data clearly claimed that pomegranate, described as the new &#x0201c;super fruit&#x0201d; [<xref rid="pone.0160305.ref008" ref-type="bibr">8</xref>], has several health benefits. Pomegranates can help prevent or treat various disease risk factors including high blood pressure, high cholesterol, oxidative stress, hyperglycemia, and inflammatory activities [<xref rid="pone.0160305.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0160305.ref010" ref-type="bibr">10</xref>]. In fact, supplementation in pomegranate juice (POMj), containing high levels of polyphenols, was shown to: (i) reduce free radicals, oxidative stress and lipid peroxidation (-65%) [<xref rid="pone.0160305.ref011" ref-type="bibr">11</xref>], (ii) reduce risk of cardiovascular diseases [<xref rid="pone.0160305.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0160305.ref012" ref-type="bibr">12</xref>] by reducing high systolic blood pressure (-12%), carotid artery thickness (-30%), low-density lipoprotein cholesterol (LDL) oxidation (-90%), and by enhancing myocardial blood flow (+17%) [<xref rid="pone.0160305.ref013" ref-type="bibr">13</xref>] and antioxidant status (+130%) [<xref rid="pone.0160305.ref009" ref-type="bibr">9</xref>], and (ii) promote inhibition of some cellular transcription factors such as the nuclear factor NF-&#x003ba;B (NF-&#x003ba;B), tumor necrosis factor &#x003b1; (TNF&#x003b1;) and cyclooxygenase-2 (COX -2) [<xref rid="pone.0160305.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0160305.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0160305.ref015" ref-type="bibr">15</xref>], block their production and combat inflammatory degeneration of cartilage to protect articulations [<xref rid="pone.0160305.ref016" ref-type="bibr">16</xref>]. Additionally, in a spectrophotometric comparative study between POMj, red wine, blueberry juice, cranberry juice, orange juice and green tea [<xref rid="pone.0160305.ref017" ref-type="bibr">17</xref>], POMj was found to have the highest capacity to destroy free radicals and to reduce LDL oxidation and inhibit cellular oxidative stress in macrophages, with an antioxidant activity (Trolox equivalent antioxidant capacity: TEAC = 18&#x02013;20) three times higher than red wine and green tea (6&#x02013;8 TEAC) [<xref rid="pone.0160305.ref017" ref-type="bibr">17</xref>]. The efficacy of POMj is mainly due to its high bioavailability compared to other polyphenols such as resveratrol [<xref rid="pone.0160305.ref018" ref-type="bibr">18</xref>]. The underlying mechanisms of the biological polyphenol benefits are not yet clear but it was clearly proved especially in people placed under stressful situations [<xref rid="pone.0160305.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0160305.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0160305.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0160305.ref019" ref-type="bibr">19</xref>]. In this context, despite the numerous health benefits of POMj in people under stress and despite that intensive physical exercise is one of the most stressed situations characterized by acute and delayed alteration in organism&#x02019;s responses, few studies associated the effect of the pomegranate with the physical exercise [<xref rid="pone.0160305.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>]. These studies mainly focused on potential effect of dietary supplements in POMj on muscle recovery from a bout of intense eccentric exercise [<xref rid="pone.0160305.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>]. In untrained subjects, Trombold et al. [<xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>] showed that a daily drink of 500ml POMj for five days prior to damaging eccentric exercise significantly improves the strength recovery 2&#x02013;3 days after the exercise. However, these authors failed to find a significant effect upon the levels of muscle damage (creatine kinase (CK) and myoglobin) and inflammatory (interleukin-6, and CRP) markers during recovery. In another study conducted in trained participants (i.e. weight trained), it has been found that 15 days of drinking POMj (i.e., twice daily of 250ml) improve the arm strength during the 2 to 168-hour period post exercise and reduce significantly the elbow flexor muscle soreness for 48 and 72 hours post exercise [<xref rid="pone.0160305.ref003" ref-type="bibr">3</xref>]. However, isometric strength and muscle soreness in the knee extensors were not significantly affected by POMj supplementation compared to PLA. These authors conclude that POMj supplementation attenuates weakness and reduces soreness of the arm muscle but not leg muscles. Recently, Machin et al [<xref rid="pone.0160305.ref021" ref-type="bibr">21</xref>], searching for an optimal dose of pomegranate supplementation, showed that either once-daily or twice-daily dietary pomegranate juice supplementation improves strength recovery of both leg and arm muscles after an unaccustomed eccentric exercise. To the best of the authors&#x02019; knowledge, it seems to be no studies that examined the acute and delayed effects of POMj supplementation on performance and recovery after exercises involving whole body muscles (i.e. Olympic weightlifting exercises). Given the lack of research in this field and the contradictory results, the purposes of the present study were to check if natural POMj supplementation during the morning training session and 48h before could thwart the decline in the morning weightlifting performance and reduce the acute and delayed biochemical and muscle soreness responses.</p></sec><sec sec-type="materials|methods" id="sec007"><title>Methods</title><p>The authors confirm that all ongoing and related trials for this intervention are registered.</p><sec id="sec008"><title>Participants</title><p>Nine male elite weightlifters (age: 21 &#x000b1; 0.5 years, body mass: 80 &#x000b1; 9.5 kg, height 175 &#x000b1; 8.1 cm (mean &#x000b1; SD)) volunteered to participate in this study. The participants were recruited on the basis of: (i) they trained at least five sessions per week (between 15h:30 and 17h:30) with 90 to 120 min per session,(ii) they had an experience of more than 3 years in Olympic weightlifting and (iii) they didn&#x02019;t have any injuries and they didn&#x02019;t use any antioxidant (e.g., vitamin E, A, C etc.) or anti-inflammatory drugs during the experimental period and one month before. After receiving a thorough explanation of the possible risks and discomforts associated to the experimental procedures, each participant provided a written informed consent to take part in the experiment. The study was conducted according to the Declaration of Helsinki. The protocol (<xref ref-type="supplementary-material" rid="pone.0160305.s002">S1 Protocol</xref>) and the consent form were fully approved by the review board &#x0201c;Local committee of the Laboratory of Biochemistry, CHU Habib Bourguiba, Sfax, Tunisia&#x0201d; before the commencement of the assessments.</p></sec><sec id="sec009" sec-type="materials|methods"><title>Experimental design</title><p>One week before the start of the experimental period (01/01/2015), the heaviest weight lifted in a single repetition (1-RM) was assessed for each participant in each Olympic movement <xref ref-type="fig" rid="pone.0160305.g001">Fig 1</xref>. After an ascending warm-up (i.e., 1<sup>st</sup> set with 8 to 10 repetitions at 50%, 2<sup>nd</sup> set with 3 to 5 repetitions at 75% and 3<sup>rd</sup> set with 1 to 3 repetitions at 90% of athlete's estimated maximum), 1-RM was assessed in three trials with 5 min recovery time in-between [<xref rid="pone.0160305.ref022" ref-type="bibr">22</xref>]. As suggested by Kraemer and Fry [<xref rid="pone.0160305.ref023" ref-type="bibr">23</xref>], on-going encouragement and communication with the athletes during this testing is crucial to obtain the best performance. Also, estimated 1-RM was verified in the next two days. Then participants performed-as part of their habitual training program from 08h:00 to 09h:45- two training sessions <xref ref-type="fig" rid="pone.0160305.g001">Fig 1</xref> using respectively, PLA (07/01/2015) and POMj (09/01/2015) supplementations with a recovery period of 48 h in between. Supplements (1500 ml) of PLA or POMj were taken three times daily in the 48h that proceeded respectively these two training sessions (i.e. 250ml &#x000d7; 6 times with 8-h intervals between it). Moreover, 1h before the training sessions, participants consumed an additional 500 ml of PLA and 500 ml of POMj, respectively <xref ref-type="fig" rid="pone.0160305.g001">Fig 1</xref>. Upon arrival for their first test session, each participant's body mass (Tanita, Tokyo, Japan) and height were recorded. Moreover, before and after each training session, oral temperature was recorded with a calibrated digital clinical thermometer (Omron, Paris, France; accuracy: 0.05&#x000b0;C) inserted sublingually for at least 3 min with the participant in a seated resting position for at least 15 min. In addition, before and after each training session, fasting blood samples (blood sample 2, 3, 4 and 5, <xref ref-type="fig" rid="pone.0160305.g001">Fig 1</xref>) were collected and heart rate (HR) and systolic blood pressure (SBP) were recorded using a heart rate monitor and a manual sphygmomanometer. Additionally, to assess the recovery kinetic of the biological parameters, blood sample, temperature, HR and SBP were collected at resting state (i.e., after 10 days of recovery, blood sample 6) and immediately (3min) after the training session which preceded the PLA session (blood sample 1). RPE was recorded after each training session [<xref rid="pone.0160305.ref024" ref-type="bibr">24</xref>]. Before test session, participants were fasting and allowed to drink only one glass of water (15&#x02013;20 cl) to avoid the effects of postprandial thermogenesis [<xref rid="pone.0160305.ref025" ref-type="bibr">25</xref>]. Based on the results of Petterson et al. [<xref rid="pone.0160305.ref005" ref-type="bibr">5</xref>] who showed that biomarkers of muscle damage remain raised for at least 7days following intensive weightlifting exercises, a recovery period of 3weeks was chosen to evaluate the biological resting state (19/01/2015). Moreover, Given that (i) previous reports postulated that a minimal period for supplementation is at least (e.g., 30&#x02013;60 minutes) before the workout [<xref rid="pone.0160305.ref026" ref-type="bibr">26</xref>] and (ii) POMj is a highly concentrated source of dietary nitrate and polyphenols [<xref rid="pone.0160305.ref027" ref-type="bibr">27</xref>], participants were asked to consume the 500 ml of POMj and PLA 60 minutes prior to the beginning of the correspondent training session to allow sufficient time for circulating nitrate and nitrite to become elevated to get an observable ergogenic effect. Additionally, given that (i) using randomized order in this study will results in consuming POMj then PLA supplementations for some participants with only 48h wash-out period, while (ii) the delayed beneficial effects of POMj could persist up to 3weeks after the interruption of consumption [<xref rid="pone.0160305.ref028" ref-type="bibr">28</xref>], authors in the present study tried to avoid any alteration in the biochemical blood levels at the beginning and during PLA administration period, by avoiding the consumption of POMj before PLA. Therefore, PLA (at first) then POMj was administrated for all participants together (non-randomized design).</p><fig id="pone.0160305.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160305.g001</object-id><label>Fig 1</label><caption><title>Experimental design.</title><p><italic>NB</italic>: the pre sessions 1 and 2 values correspond to values of 48-h recovery; Weightlifting performance was calculated during both test sessions; Acute (RPE) and delayed (DOMS) perceived muscle fatigue and soreness were assessed respectively 3min and 48 after both test sessions.</p></caption><graphic xlink:href="pone.0160305.g001"/></fig></sec><sec id="sec010"><title>Training session</title><p>Each training session includes three Olympic-Weightlifting exercises: snatch, clean and jerk, and squat [<xref rid="pone.0160305.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0160305.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0160305.ref029" ref-type="bibr">29</xref>]. After increasing the load until unsuccessful trial in the snatch and the clean and jerk, five sets for each exercise were performed (i.e., two sets at 85% of 1-RM with three repetitions per set and three sets at 90% of 1- RM with two reps per set) with a passive recovery period of 5 min in-between [<xref rid="pone.0160305.ref030" ref-type="bibr">30</xref>]. Each session was preceded by 10 min warm-up wherein the participants will perform 3&#x02013;5 repetitions with increasing loads (i.e., from 40 to 80% of the 1-RM). Performance in each session was measured by the total volume lifted in the two Olympic movements (volume lifted (kg) in snatch added volume lifted (kg) in clean and Jerk: only the right lifts are taken into consideration) [<xref rid="pone.0160305.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0160305.ref007" ref-type="bibr">7</xref>] and by the maximal lifted amounts in both Olympic movement (i.e., the maximal load lifted (kg) in the snatch added to the maximal load lifted (kg) in the clean and Jerk).</p></sec><sec id="sec011"><title>Rating of perceived exertion scale</title><p>The rating of perceived exertion (RPE) scale (15-points) runs from 6 (very, very light) to 20 (very, very hard) 10. RPE scale measures feelings of effort, strain, discomfort, and/or fatigue experienced during physical task. Although this is a subjective measure (person's exertion), RPE values were shown to provide good estimation of the increase in heart rate, muscle fatigue and several other physiological measures during physical activity [<xref rid="pone.0160305.ref024" ref-type="bibr">24</xref>].</p></sec><sec id="sec012"><title>Delayed onset of muscle soreness</title><p>Delayed onset soreness (DOMS) of the knee extensors and elbow flexors was determined 48 hours after the training sessions. Participants were asked to rate subjectively the degree of soreness in both muscles using a visual analog scale of 0 (absence of soreness) to 10 (unbearable soreness) [<xref rid="pone.0160305.ref031" ref-type="bibr">31</xref>]. Soreness was normalized to 100% of the maximal perceived level.</p></sec><sec id="sec013"><title>Dietary records</title><p>To assess the adequacy of nutrient intake, a consecutive dietary record over 7 days was completed. All participants received a detailed verbal explanation and written instructions on data collection procedures. Participants were asked to continue with their usual dietary habits during the period of dietary recording and to be as accurate as possible in recording the amounts and types of food and fluid consumed. A list of common household measures, such as cups and tablespoons, and specific information about the quantity in each measurement (grams, etc.) were given to each participant. Each individual's diet was calculated using the Bilnut 4 software package (SCDA Nutrisoft, Cerelles, France) and the food composition tables published by the Tunisian National Institute of Statistics in 1978. Estimated nutrient intakes were referred to reference dietary intakes for physically active people and the daily nutriment data showed that total calorie, macronutrient, and micronutrient intakes are situated in the interval of the reference dietary intakes for healthy Tunisian adults.</p></sec><sec id="sec014"><title>Pomegranate and placebo supplementations</title><p>The tested quantity of the natural POMj was prepared from a fresh pomegranate fruit 48h before the beginning of the experimentation and was frozen and stored at -4&#x000b0;C. No additional chemical products were added to the natural POMj. Each 500-mL of the tested POMj contained 2.56g of total polyphenol, 1.08g of orthodiphenols, 292.59mg of flavonoids and 46.75mg of flavonols. Subjects were reminded verbally through phone communication to consume at the required times their supplements. PLA juice consisted of a Pomegranate-flavored commercial drink contained water, citric acid, natural flavor and natural identical flavor (Pomegranate), sweeteners (aspartame &#x000d7; (0.3g/l), acesulfame K (0.16g/l)), stabilizers (Arabic gum) and didn&#x02019;t contain antioxidants, vitamins nor polyphenols.</p><p>Given that the daily drink of 500ml (2 &#x000d7; 250ml/day) POMj for five or fifteen days prior to an intense exercise showed contradictory effects in the recovery levels of muscle damage, as well as muscle strength and soreness [<xref rid="pone.0160305.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>], and given that the present study investigate the effect of the natural POMj consumed only 2 days before the training session, a supplementation quantity of 750ml (3 &#x000d7; 250ml /day) has been chosen.</p></sec><sec id="sec015"><title>Phenolic compounds</title><sec id="sec016"><title>Extraction of phenolic fraction</title><p>The phenolic extracts were obtained following the procedure of Chtourou et al. [<xref rid="pone.0160305.ref032" ref-type="bibr">32</xref>] with some modifications. In fact, the POMj sample (4g) was added to 2 mL of <italic>n</italic>-hexane and 4 mL of a methanol/water (60:40, v/v) mixture in a 20 mL centrifuge tube. After vigorous mixing, they were centrifuged for 3 min. The hydroalcoholic phase was collected, and the hexane phase was re-extracted twice with 4 mL of the methanol/water (60:40, v/v) solution each time. Finally, the hydro alcoholic fractions were combined, washed with 4 mL of <italic>n</italic>-hexane to remove the residual POMj, then concentrated and dried by evaporative centrifuge in vacuum at 35&#x000b0;C.</p></sec><sec id="sec017"><title>Determination of the total phenols and o-diphenols contents</title><p>The determination of the total phenolic compounds was performed by means of the Folin-Ciocalteau reagent using the method described by Gargouri et al. [<xref rid="pone.0160305.ref033" ref-type="bibr">33</xref>]. The total phenolic content was expressed as milligrams of gallic acid (GA) equivalent per kilogram of POM (y = 0.011x, R&#x000b2; = 0.990). The optical density (OD) was measured at &#x003bb; = 765 nm, using a spectrophotometer (Shimadzu UV-1800 PC, Japan). The concentration of <italic>o</italic>-diphenolic compounds in the methanolic extract was determined by the method of Dridi-Gargouri et al. [<xref rid="pone.0160305.ref034" ref-type="bibr">34</xref>]. The total <italic>o</italic>-diphenolic content was expressed as milligrams of GA equivalent per kilogram of POM (y = 1.144x, R&#x000b2; = 0.999). The OD was measured at &#x003bb; = 370 nm, using the same spectrophotometer.</p></sec><sec id="sec018"><title>Determination of total flavonoids</title><p>Total flavonoids were measured by a colorimetric assay developed by Gargouri et al. [<xref rid="pone.0160305.ref033" ref-type="bibr">33</xref>]; 1 mL aliquot of appropriately diluted sample or standard solutions of catechin (20, 40, 60, 80 and 100 mg L-1) was added to a 10-mL volumetric flask containing 4 mL double-distillate H<sub>2</sub>O. At zero time, 0.30 mL 5% NaNO<sub>2</sub> was added to the flask. After 5 min, 0.30 mL 10% AlCl<sub>3</sub> was added. At 6 min, 2 mL (1 mol L-1) NaOH was added to the mixture. Immediately, the reaction flask was diluted to volume with the addition of 2.40 mL of double-distillate H<sub>2</sub>O and thoroughly mixed. Concerning the absorbance of the mixture, pink in color, it was determined at 510 nm versus prepared water blank. As for the total flavonoids of fruits, they were expressed on a fresh weight basis as mg 100 g-1 catechin equivalents. It is worth noting that the samples were analyzed in triplicate.</p></sec></sec><sec id="sec019"><title>Blood sampling and analysis</title><p>Blood samples (7ml) were collected six times for each participant <xref ref-type="fig" rid="pone.0160305.g001">Fig 1</xref> from a forearm vein (i.e., 3.5ml in tube containing EDTA for hematological parameters and 3.5ml in tube containing Heparin for GLC, CRE, CRP and muscle damage parameters). Blood samples were collected after 5 min of being seated at rest (blood sample 6), and before the two test sessions (blood samples 2 and 4). Immediately after the training sessions (blood samples 1, 3 and 5), samples were also collected at 3min of being seated. Samples were placed in an ice bath and centrifuged immediately at 3000 rpm (&#x000d7; g) for 10 min. Aliquots of the resulting plasma were stored at -80&#x000b0;C until analysis.</p><p>To eliminate inter-assay variance, all samples were analyzed in the same assay run. All assays were performed in duplicate in the same laboratory with simultaneous use of a control serum from Randox. Hematological parameters (i.e., white blood cells (WBC), neutrophils (NEU), red blood cells (RBC), and platelets (PLT) were performed within 3h in a multichannel automated blood cell analyzer Beckman Coulter Gen system-2 (Coulter T540). Plasma glucose (GLC), Creatinine (CRE), muscle damage markers and CRP were determined spectrophotometrically using Architect Ci 4100 d'ABOTT. CK, Alkaline phosphate (PAL), lactate dehydrogenase (LDH) and CRP were respectively measured with N-acetyl-L-cysteine method; the hydrolyze of phosphate parametrophenyl method; the oxidation of lactate on pyruvate method and the immunoturbidimetric method. The intra-assay coefficients of variation for these parameters kit were respectively 1.3%, 2.3%, 0.2% and 1.16%. Aspartate aminotransferase (ASAT) was determined by measuring NADH oxidation with intra-assay coefficient of variation of 1.1.</p></sec><sec id="sec020"><title>Statistical analyses</title><p>All statistical tests were processed using STATISTICA 10.0 Software (Stat-Soft, Maisons-Alfort, France). Normality of the distribution was confirmed using the Shapiro&#x02013;Wilks W-test. Paired simple t-test was used to analyze the effect of POMj supplementation on physical performances and RPE. To analyze the effect of POMj supplementation on the biological responses during training sessions (pre-post values), a two-way ANOVA (2 levels [supplementation (PLA and POMj] &#x000d7; 2 levels [training (Pre and Post]) with repeated measures was used. To analyze the effect of POMj supplementation in the recovery kinetic of the selected parameters, one-way ANOVA was used. Post hoc tests were conducted when significant main effects were found using Tukey's honest significance difference (HSD) test. Effect sizes were calculated as partial eta-squared (&#x003b7;<sub>p</sub><sup>2</sup>) for the ANOVA analysis and as Cohen's d for the paired sample t-test to assess the practical significance of the findings. Pearson correlation was used to assess the correlation between DOMS and CK values. Significance was set at p &#x0003c; 0.05.</p></sec></sec><sec sec-type="results" id="sec021"><title>Results</title><sec id="sec022"><title>Effect of pomegranate supplementation on physical performance, rating of perceived exertion and delayed onset soreness</title><p>Measurements of physical performance (i.e., Total lifted amount and maximal lifted amount) after using PLA and POMj supplementation were presented in <xref ref-type="fig" rid="pone.0160305.g002">Fig 2</xref>. Statistical analysis showed a significant POMj supplementation effect in both calculated performances (t = -2.37, p&#x0003c;0.05, d = -0.3 and t = -2.4, p&#x0003c;0.05, d = -0.1, respectively) during POMj condition compared to PLA (i.e., rate of increase = +8.29&#x000b1;3.8% and +3.26&#x000b1;0.83%, respectively for the total and the maximal lifted amounts). Similarly, RPE <xref ref-type="fig" rid="pone.0160305.g003">Fig 3</xref> and DOMS (i.e., knee extensors; <xref ref-type="fig" rid="pone.0160305.g004">Fig 4</xref>) values showed significant effects of supplement (t = 2.4, p&#x0003c;0.05, d = 0.18 and t = 4, p&#x0003c;0.01, d = 0.42, respectively) with lower values being measured during POMj condition (i.e., rate of decrease = -4.37&#x000b1;1.45% for RPE and -13.4&#x000b1;3.84% for the knee extensors&#x02019; DOMS).</p><fig id="pone.0160305.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160305.g002</object-id><label>Fig 2</label><caption><title>Calculated performances with PLA and natural POMj supplementations.</title><p>*:Significant differences between PLA and POMj conditions.</p></caption><graphic xlink:href="pone.0160305.g002"/></fig><fig id="pone.0160305.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160305.g003</object-id><label>Fig 3</label><caption><title>RPE values using Placebo and natural POMj supplementations.</title><p>*: Significant differences between PLA and POMj conditions.</p></caption><graphic xlink:href="pone.0160305.g003"/></fig><fig id="pone.0160305.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160305.g004</object-id><label>Fig 4</label><caption><title>DOMS values using PLA and natural POMj supplementations.</title><p>*: Significant differences between PLA and POMj conditions; k: Significant differences between DOMS of knee extensors and DOMS of elbow flexors.</p></caption><graphic xlink:href="pone.0160305.g004"/></fig><p>However, for the DOMS of the elbow flexors muscles <xref ref-type="fig" rid="pone.0160305.g004">Fig 4</xref>, no POMj effect was shown (p&#x0003e;0.05). In both conditions, delayed soreness of the knee extensors was higher (p&#x0003c;0.001) than delayed soreness of elbow flexors (i.e., 74.4&#x000b1;4.4% vs 32.2&#x000b1;3.6% and 61.1&#x000b1;5.1% vs 25.5&#x000b1;3.7%). For both muscle groups, significant correlations between the delayed soreness and the CK levels were shown (p&#x0003c;0.001) with r = 0.8 between the CK level and the DOMS of the knee extensors and r = 0.7 between the CK level and the DOMS of the elbow flexors.</p></sec><sec id="sec023"><title>Effect of pomegranate on the biological parameters before and after the training sessions</title><p>The biological responses during the weightlifting training sessions were presented in <xref ref-type="table" rid="pone.0160305.t001">Table 1</xref> for both PLA and POMj supplementation.</p><table-wrap id="pone.0160305.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160305.t001</object-id><label>Table 1</label><caption><title>Acute biological responses to weightlifting training sessions using natural POMj and PLA supplementations.</title></caption><alternatives><graphic id="pone.0160305.t001g" xlink:href="pone.0160305.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Variables</th><th align="center" colspan="3" rowspan="1">Placebo</th><th align="center" colspan="3" rowspan="1">Pomegranate</th><th align="center" rowspan="2" colspan="1">&#x00394; (POMj-PLA) in %</th><th align="center" colspan="3" rowspan="1">ANOVA</th></tr><tr><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">% of change</th><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">% of change</th><th align="center" rowspan="1" colspan="1">Pomegranate effect</th><th align="center" rowspan="1" colspan="1">Training effect</th><th align="center" rowspan="1" colspan="1">Interaction</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Temperature</bold> (&#x000b0;C)</td><td align="center" rowspan="1" colspan="1">36.14&#x000b1;0.69</td><td align="center" rowspan="1" colspan="1">36.98&#x000b1;0.51 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+02.32%</td><td align="center" rowspan="1" colspan="1">36.06&#x000b1;0.82</td><td align="center" rowspan="1" colspan="1">37.03&#x000b1;0.48 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+02.74%</td><td align="center" rowspan="1" colspan="1">+00.42%</td><td align="center" rowspan="1" colspan="1">F = 0.1, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.01</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 22</italic>.<italic>8</italic>, <italic>p&#x0003c;0</italic>.<italic>01</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>7</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 2.1, p&#x0003e;0,05, &#x003b7;p<sup>2</sup> = 0.2</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HR</bold> (bpm)</td><td align="center" rowspan="1" colspan="1">72.44&#x000b1;9.00</td><td align="center" rowspan="1" colspan="1">85.11&#x000b1;10.6 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+18.22%</td><td align="center" rowspan="1" colspan="1">70.78&#x000b1;9.64</td><td align="center" rowspan="1" colspan="1">79.78&#x000b1;7.93 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+13.76%</td><td align="center" rowspan="1" colspan="1">-04.46%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 9</italic>.<italic>6</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>5</italic></bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 18</italic>.<italic>6</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>6</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 4.1, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.3</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>SBP</bold> (mmHg)</td><td align="center" rowspan="1" colspan="1">12.49&#x000b1;0.96</td><td align="center" rowspan="1" colspan="1">13.67&#x000b1;0.35 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+09.89%</td><td align="center" rowspan="1" colspan="1">11.59&#x000b1;0.37 <xref ref-type="table-fn" rid="t001fn003"><sup><bold>P</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">12.52&#x000b1;0.72 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+8.08%</td><td align="center" rowspan="1" colspan="1">-01.81%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 13</italic>.<italic>7</italic>, <italic>p&#x0003c;0</italic>.<italic>01</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>6</italic></bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 26</italic>.<italic>7</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>7</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 1.1, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>GLC</bold> (mmol/l)</td><td align="center" rowspan="1" colspan="1">05.02&#x000b1;0.50</td><td align="center" rowspan="1" colspan="1">05.05&#x000b1;0.59</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">04.80&#x000b1;0.41</td><td align="center" rowspan="1" colspan="1">04.30&#x000b1;0.67 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">-10.59%</td><td align="center" rowspan="1" colspan="1">&#x02014;&#x02014;&#x02014;</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 9</italic>.<italic>7</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>5</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 3.1, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.3</td><td align="center" rowspan="1" colspan="1">F = 1.1, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>CRE</bold> (&#x003bc;mol/l)</td><td align="center" rowspan="1" colspan="1">82.00&#x000b1;8.26</td><td align="center" rowspan="1" colspan="1">83.67&#x000b1;9.43</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">82.11&#x000b1;8.75</td><td align="center" rowspan="1" colspan="1">87.33&#x000b1;10.3 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+6.32%</td><td align="center" rowspan="1" colspan="1">&#x02014;&#x02014;&#x02014;</td><td align="center" rowspan="1" colspan="1">F = 1.45, p&#x0003e;0.05, &#x003b7;p2 = 0.1</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 14</italic>.<italic>67</italic>, <italic>p&#x0003c;0</italic>.<italic>01</italic>, <italic>&#x003b7;p2 = 0</italic>.<italic>7</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 5.2, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.2</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>WBC</bold> (10<sup>3</sup> /&#x003bc;l)</td><td align="center" rowspan="1" colspan="1">08.62&#x000b1;2.67</td><td align="center" rowspan="1" colspan="1">07.52&#x000b1;2.03 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">-11.36%</td><td align="center" rowspan="1" colspan="1">08.36&#x000b1;2.19</td><td align="center" rowspan="1" colspan="1">07.39&#x000b1;1.85</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">&#x02014;&#x02014;&#x02014;</td><td align="center" rowspan="1" colspan="1">F = 1.1, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.1</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 12</italic>.<italic>9</italic>, <italic>p&#x0003c;0</italic>.<italic>01</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>6</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 0.1, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>NEU</bold> (10<sup>3</sup> / &#x003bc;l)</td><td align="center" rowspan="1" colspan="1">05.34&#x000b1;2.12</td><td align="center" rowspan="1" colspan="1">04.87&#x000b1;1.86 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">-07.97%</td><td align="center" rowspan="1" colspan="1">04.83&#x000b1;1.90 <xref ref-type="table-fn" rid="t001fn003"><sup><bold>P</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">04.68&#x000b1;1.92</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">&#x02014;&#x02014;&#x02014;</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 9</italic>.<italic>9</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>5</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 3.8, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.3</td><td align="center" rowspan="1" colspan="1">F = 1.4, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>RBC</bold> (10<sup>6</sup> / &#x003bc;l)</td><td align="center" rowspan="1" colspan="1">06.08&#x000b1;0.54</td><td align="center" rowspan="1" colspan="1">05.43&#x000b1;0.41 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">-10.34%</td><td align="center" rowspan="1" colspan="1">05.51&#x000b1;0.59</td><td align="center" rowspan="1" colspan="1">05.55&#x000b1;0.24</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">&#x02014;&#x02014;&#x02014;</td><td align="center" rowspan="1" colspan="1">F = 2.14, p&#x0003e;0.05, &#x003b7;p2 = 0.1</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 13</italic>.<italic>3</italic>, <italic>p&#x0003c;0</italic>.<italic>01</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>5</italic></bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 7</italic>.<italic>1</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>6</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PLT</bold> (10<sup>3</sup> / &#x003bc;l)</td><td align="center" rowspan="1" colspan="1">162.1&#x000b1;38.2</td><td align="center" rowspan="1" colspan="1">200.3&#x000b1;42.9 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+24.97%</td><td align="center" rowspan="1" colspan="1">184.1&#x000b1;43.6 <xref ref-type="table-fn" rid="t001fn003"><sup><bold>P</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">199.8&#x000b1;48.7</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">&#x02014;&#x02014;&#x02014;</td><td align="center" rowspan="1" colspan="1">F = 1.49, p&#x0003e;0.05, &#x003b7;p2 = 0.1</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 14</italic>.<italic>1</italic>, <italic>p&#x0003c;0</italic>.<italic>01</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>7</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 1.2, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>CK</bold> (UI/L)</td><td align="center" rowspan="1" colspan="1">342.4&#x000b1;42.2</td><td align="center" rowspan="1" colspan="1">440.3&#x000b1;56.2 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+28.28%</td><td align="center" rowspan="1" colspan="1">262.1&#x000b1;19.6 <xref ref-type="table-fn" rid="t001fn003"><sup><bold>P</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">311.8&#x000b1;21.4 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+19.53%</td><td align="center" rowspan="1" colspan="1">-8.75%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 9</italic>. <italic>3</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>5</italic></bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 42</italic>.<italic>2</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>7</italic></bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 9</italic>.<italic>8</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>5</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>LDH</bold> (U/l)</td><td align="center" rowspan="1" colspan="1">169.7&#x000b1;24.9</td><td align="center" rowspan="1" colspan="1">198.3&#x000b1;43.9 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+16.26%</td><td align="center" rowspan="1" colspan="1">156.0&#x000b1;23.3 <xref ref-type="table-fn" rid="t001fn003"><sup><bold>P</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">178.6&#x000b1;25.4 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+14.61%</td><td align="center" rowspan="1" colspan="1">-1.64%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 5</italic>.<italic>7</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>4</italic></bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 31</italic>,<italic>1</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>7</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 0.06, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.2</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>ASAT</bold> (UI/l)</td><td align="center" rowspan="1" colspan="1">26.11&#x000b1;7.61</td><td align="center" rowspan="1" colspan="1">30.44&#x000b1;9.15 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+16.59%</td><td align="center" rowspan="1" colspan="1">23.33&#x000b1;5.29</td><td align="center" rowspan="1" colspan="1">26.22&#x000b1;4.14</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">&#x02014;&#x02014;&#x02014;</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 5</italic>.<italic>9</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>4</italic></bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 37</italic>.<italic>9</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>6</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 0.01, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PAL</bold> (UI/l)</td><td align="center" rowspan="1" colspan="1">72.44&#x000b1;13.5</td><td align="center" rowspan="1" colspan="1">75.67&#x000b1;13.8 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+04.51%</td><td align="center" rowspan="1" colspan="1">72.78&#x000b1;16.4</td><td align="center" rowspan="1" colspan="1">72.67&#x000b1;14.3</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">&#x02014;&#x02014;&#x02014;</td><td align="center" rowspan="1" colspan="1">F = 0.7, p&#x0003e;0.5, &#x003b7;p<sup>2</sup> = 0.1</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 6</italic>.<italic>4</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>4</italic></bold></td><td align="center" rowspan="1" colspan="1">F = 3.1, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.3</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>CRP</bold> (mg/l)</td><td align="center" rowspan="1" colspan="1">01.39&#x000b1;0.91</td><td align="center" rowspan="1" colspan="1">01.48&#x000b1;0.91 <xref ref-type="table-fn" rid="t001fn002"><sup><bold>*</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">+12.59%</td><td align="center" rowspan="1" colspan="1">01.30&#x000b1;0.88</td><td align="center" rowspan="1" colspan="1">01.32&#x000b1;0.89</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">&#x02014;&#x02014;&#x02014;</td><td align="center" rowspan="1" colspan="1">F = 2.6, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.01</td><td align="center" rowspan="1" colspan="1">F = 5.1, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.4</td><td align="center" rowspan="1" colspan="1">F = 2.5, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.14</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Temperature, Heart rate (HR), Systolic blood pressure (SBP), Blood Glucose (GLC), Creatinine (CRE), White blood cells (WBC), Neutrophils (NEU), Red blood cells (RBC), Platelets (PLT), Creatinine kinase (CK), Lactate dehydrogenase (LDH), Aspartate aminotransferase (ASAT), Alkaline phosphate (PAL) and C-reactive protein (CRP) represented as mean &#x000b1; <inline-formula id="pone.0160305.e001"><alternatives><graphic id="pone.0160305.e001g" xlink:href="pone.0160305.e001"/><mml:math id="M1"><mml:msub><mml:mi mathvariant="normal">S</mml:mi><mml:mover accent="true"><mml:mi mathvariant="normal">x</mml:mi><mml:mo>&#x000af;</mml:mo></mml:mover></mml:msub></mml:math></alternatives></inline-formula> at pre and post training sessions using POMj and PLA supplementations.</p></fn><fn id="t001fn002"><p><sup><bold>*</bold></sup> Significant differences between pre-post training sessions.</p></fn><fn id="t001fn003"><p><sup>P</sup> Significant differences between POMj and PLA values at pre training sessions (i.e., 48h recovery).</p></fn></table-wrap-foot></table-wrap><sec id="sec024"><title>Effect of POMj on core temperature, heart rate systolic blood pressure, glucose and creatinine</title><p><bold>Acute effect:</bold> Statistical analysis showed a significant increase pre-post training session for core temperature, HR and SBP in both conditions (p&#x0003c;0.001) with higher rate of increase for core temperature (+0.42%) and lower rate of increase for HR and SBP (-4.46% and -1.81%) during POMj condition. There is also a significant difference pre-post training session for GLC and CRE only using POMj with lower post training values for GLC (p&#x0003c;0.05, rate of decrease = -10.59&#x000b1;3.51%) and higher one for the CRE (p&#x0003c;0.05, rate of increase = +6.32&#x000b1;1.57%).</p><p><bold>Delayed effect:</bold> Additionally, a significant difference in pre-training sessions values (i.e., after 48h recovery using 1.5L of PLA vs. 1.5L of POMj supplementations) was recorded for SBP with lower values using POMj supplementation (p&#x0003c;0.01).</p><p>For these parameters, a significant effect of POMj supplementation were recorded for HR and GLC with p&#x0003c;0.05 and for SBP with p&#x0003c;0.01 and significant effects of training session were recorded for core temperature, HR, SBP, and CRE (p&#x0003c;0.01, p&#x0003c;0.05, p&#x0003c;0.001 and p&#x0003c;0.01, respectively) while no interaction POMj supplementation &#x000d7; Training session was registered.</p></sec><sec id="sec025"><title>Effect of POMj on hematological parameters</title><p><bold>Acute effect:</bold> Concerning the hematological parameters, during the PLA condition, all the parameters showed a significant difference pre-post training session with lower post-training values for WBC, NEU and RBC (p&#x0003c;0.05, rate of decrease = -11.36&#x000b1;3.66%, -7.97 &#x000b1;4.11% and -10.34&#x000b1;2.02%, respectively) and higher post-training values for PLT (p&#x0003c;0.01; rate of increase = +24.97&#x000b1;9.95%). Using POMj supplementation, no significant change pre-post session was registered (p&#x0003e;0.05) for all the selected parameters.</p><p><bold>Delayed effects:</bold> The comparison of the pre-training values in both conditions, shows a significant difference for NEU and PLT with lower pre-training values for NEU (p&#x0003c;0.05) and higher ones for PLT (p&#x0003c;0.05) using POMj supplementation.</p><p>For these parameters, significant POMj effects were registered for NEU (p&#x0003c;0.05), significant training effects were registered for WBC, RBC and PLT (p&#x0003c;0.001) and a significant interaction POMj supplementation &#x000d7; Training session was registered for RBC (p&#x0003c;0.05).</p></sec><sec id="sec026"><title>Effect of pomegranate on muscle damage parameters and C&#x02014;reactive protein</title><p><bold>Acute effects:</bold> For the muscle damage and inflammatory markers, during both PLA and POMj conditions, significant increases pre-post training sessions were registered for CK and LDH (p&#x0003c;0.001 and p&#x0003c;0.01) with lower rate of increase (-8.75% and -1.64%) using POMj supplementation. However, ASAT, PAL and CRP showed a significant difference (p&#x0003c;0.05) pre-post training session only with PLA condition with higher values at post-training session (rate of increase = +16.59%, +04.51% and +12.59% respectively).</p><p><bold>Delayed effects:</bold>The comparison of the pre-training values in both conditions, showed a significant difference only for CK (p&#x0003c;0.001) and LDH (p&#x0003c;0.05) with lower values using POMj.</p><p>Similarly, significant POMj supplementation (p&#x0003c;0.05) and training session effect (p&#x0003c;0.001) were registered for these three markers (i.e., CK, LDH and ASAT). However, for PAL and CRP, only significant training effects (p&#x0003c;0.05) was registered for PAL. A significant interaction POMj supplementation &#x000d7; Training session was registered only for CK (p&#x0003c;0.05).</p></sec><sec id="sec027"><title>Recovery kinetic of the biological parameters using placebo and pomegranate supplementations</title><p>Tables <xref ref-type="table" rid="pone.0160305.t002">2</xref> and <xref ref-type="table" rid="pone.0160305.t003">3</xref> show the values of biological parameters at resting state and immediately and 48 after the training sessions during respectively PLA and POMj conditions.</p><table-wrap id="pone.0160305.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160305.t002</object-id><label>Table 2</label><caption><title>Effect of 48h of recovery period associated to PLA supplementation in the biological responses.</title></caption><alternatives><graphic id="pone.0160305.t002g" xlink:href="pone.0160305.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Variables</th><th align="center" colspan="3" rowspan="1">Placebo</th><th align="center" rowspan="2" colspan="1">&#x00394; 48h-3&#x02019; in %</th><th align="center" rowspan="2" colspan="1">ANOVA</th></tr><tr><th align="left" rowspan="1" colspan="1">3&#x02019;Post training</th><th align="left" rowspan="1" colspan="1">48h recovery</th><th align="center" rowspan="1" colspan="1">Rest values</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Temperature</bold> (&#x000b0;C)</td><td align="center" rowspan="1" colspan="1">37.03&#x000b1;0.45</td><td align="center" rowspan="1" colspan="1">36.14&#x000b1;0.69<xref ref-type="table-fn" rid="t002fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">36.18&#x000b1;0.69</td><td align="center" rowspan="1" colspan="1">-02.39%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 14</italic>.<italic>6</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>4</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HR</bold> (bpm)</td><td align="center" rowspan="1" colspan="1">86.56&#x000b1;8.60</td><td align="center" rowspan="1" colspan="1">72.44&#x000b1;9.00<xref ref-type="table-fn" rid="t002fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">69.78&#x000b1;9.74</td><td align="center" rowspan="1" colspan="1">-16.04%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 30</italic>.<italic>2</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>4</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>SBP</bold> (mmHg)</td><td align="center" rowspan="1" colspan="1">13.44&#x000b1;0.56</td><td align="center" rowspan="1" colspan="1">12.49&#x000b1;0.96<xref ref-type="table-fn" rid="t002fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">12.17&#x000b1;0.90</td><td align="center" rowspan="1" colspan="1">-07.19%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 37</italic>.<italic>0</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>5</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>GLC</bold> (mmol/l)</td><td align="center" rowspan="1" colspan="1">05.08&#x000b1; 0.59</td><td align="center" rowspan="1" colspan="1">05.02&#x000b1;0.50</td><td align="center" rowspan="1" colspan="1">04.88&#x000b1;0.48</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">F = 0.74, p&#x0003e;0.05, &#x003b7;p2 = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>CRE</bold> (&#x003bc;mol/l)</td><td align="center" rowspan="1" colspan="1">83.56&#x000b1;8.23</td><td align="center" rowspan="1" colspan="1">82.00&#x000b1;8.26</td><td align="center" rowspan="1" colspan="1">83.44&#x000b1;9.18</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">F = 2.98, p&#x0003e;0.05, &#x003b7;p2 = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>WBC</bold> (10<sup>3</sup> /&#x003bc;l)</td><td align="center" rowspan="1" colspan="1">07.77&#x000b1;2.11</td><td align="center" rowspan="1" colspan="1">08.62&#x000b1;2.67<xref ref-type="table-fn" rid="t002fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">08.17&#x000b1;2.25</td><td align="center" rowspan="1" colspan="1">+10.82%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 3</italic>.<italic>67</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>. <italic>3</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>NEU</bold> (10<sup>3</sup> /&#x003bc;l)</td><td align="center" rowspan="1" colspan="1">04.99&#x000b1;1.41</td><td align="center" rowspan="1" colspan="1">05.34&#x000b1;2.12</td><td align="center" rowspan="1" colspan="1">05.19&#x000b1;1.68</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">F = 0.71, p&#x0003e;0.05, &#x003b7;p2 = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>RBC</bold> (10<sup>6</sup> / &#x003bc;l)</td><td align="center" rowspan="1" colspan="1">05.90&#x000b1;0.62</td><td align="center" rowspan="1" colspan="1">06.08&#x000b1;0.54</td><td align="center" rowspan="1" colspan="1">05.73&#x000b1;0.63</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">F = 1.99, p&#x0003e;0.05, &#x003b7;p2 = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PLT</bold> (10<sup>3</sup> /&#x003bc;l)</td><td align="center" rowspan="1" colspan="1">196.8&#x000b1;37.1</td><td align="center" rowspan="1" colspan="1">162.11&#x000b1;38.2<xref ref-type="table-fn" rid="t002fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">181.9&#x000b1;46.0</td><td align="center" rowspan="1" colspan="1">-16.07%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 4</italic>.<italic>16</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p2 = 0</italic>.<italic>4</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>CK</bold> (UI/L)</td><td align="center" rowspan="1" colspan="1">451.2&#x000b1;55.8</td><td align="center" rowspan="1" colspan="1">342.4&#x000b1;42.2<xref ref-type="table-fn" rid="t002fn002"><sup><bold>A</bold></sup></xref><xref ref-type="table-fn" rid="t002fn003"><sup><bold>B</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">237.4&#x000b1;36.5</td><td align="center" rowspan="1" colspan="1">-23.98%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 29</italic>.<italic>3</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>5</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>LDH</bold> (U/l)</td><td align="center" rowspan="1" colspan="1">197.2&#x000b1;40.1</td><td align="center" rowspan="1" colspan="1">169.7&#x000b1;24.9<xref ref-type="table-fn" rid="t002fn002"><sup><bold>A</bold></sup></xref><xref ref-type="table-fn" rid="t002fn003"><sup><bold>B</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">145.3&#x000b1;18.2</td><td align="center" rowspan="1" colspan="1">-12.97%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 37</italic>.<italic>8</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>3</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>ASAT</bold> (UI/L)</td><td align="center" rowspan="1" colspan="1">30.77&#x000b1;7.59</td><td align="center" rowspan="1" colspan="1">26.11&#x000b1;7.61<xref ref-type="table-fn" rid="t002fn002"><sup><bold>A</bold></sup></xref><xref ref-type="table-fn" rid="t002fn003"><sup><bold>B</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">20.11&#x000b1;3.82</td><td align="center" rowspan="1" colspan="1">-14.70%</td><td align="center" rowspan="1" colspan="1"><bold><italic>F = 16</italic>.<italic>3</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>4</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PAL</bold> (UI/L)</td><td align="center" rowspan="1" colspan="1">70.67&#x000b1;12.9</td><td align="center" rowspan="1" colspan="1">72.44&#x000b1;13.5</td><td align="center" rowspan="1" colspan="1">73.22&#x000b1;16.0</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">F = 2.16, p&#x0003e;0.05, &#x003b7;p2 = 0.2</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>CRP</bold> (mg/l)</td><td align="left" rowspan="1" colspan="1">01.46&#x000b1;0.90</td><td align="center" rowspan="1" colspan="1">01.39&#x000b1;0.91</td><td align="left" rowspan="1" colspan="1">01.24&#x000b1;0.70</td><td align="center" rowspan="1" colspan="1">NS&#x000a0;</td><td align="center" rowspan="1" colspan="1">F = 2.87, p&#x0003e;0.05, &#x003b7;p2 = 0.7</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Temperature, Heart rate (HR), Systolic blood pressure (SBP), Blood Glucose (GLC), Creatinine (CRE), White blood cells (WBC), Neutrophils (NEU), Red blood cells (RBC), Platelets (PLT), Creatinine kinase (CK), Lactate dehydrogenase (LDH), Aspartate aminotransferase (ASAT), Alkaline phosphate (PAL) and C-reactive protein (CRP) represented as mean &#x000b1; <inline-formula id="pone.0160305.e002"><alternatives><graphic id="pone.0160305.e002g" xlink:href="pone.0160305.e002"/><mml:math id="M2"><mml:msub><mml:mi mathvariant="normal">S</mml:mi><mml:mover accent="true"><mml:mi mathvariant="normal">x</mml:mi><mml:mo>&#x000af;</mml:mo></mml:mover></mml:msub></mml:math></alternatives></inline-formula> at rest, 3min and 48h post training session using PLA supplementations.</p></fn><fn id="t002fn002"><p><sup>A</sup> Significant differences between 48h and 3min post training session.</p></fn><fn id="t002fn003"><p><sup>B</sup> Significant difference between 48h recovery and rest values. <italic>NB: 3&#x02019; Post training correspond to blood sample 1, 48h recovery correspond to blood sample 2 and rest correspond to blood sample 6 <xref ref-type="fig" rid="pone.0160305.g001">Fig 1</xref></italic></p></fn></table-wrap-foot></table-wrap><table-wrap id="pone.0160305.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160305.t003</object-id><label>Table 3</label><caption><title>Effect of 48h of recovery period associated to POMj supplementation in the biological responses.</title></caption><alternatives><graphic id="pone.0160305.t003g" xlink:href="pone.0160305.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Variables</th><th align="center" colspan="3" rowspan="1">Pomegranate</th><th align="center" rowspan="2" colspan="1">&#x00394; 48h-3&#x02019; in %</th><th align="center" rowspan="2" colspan="1">ANOVA</th></tr><tr><th align="left" rowspan="1" colspan="1">3&#x02019;Post training</th><th align="left" rowspan="1" colspan="1">48h recovery</th><th align="left" rowspan="1" colspan="1">Rest values</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Temperature</bold> (&#x000b0;C)</td><td align="center" rowspan="1" colspan="1">36.98&#x000b1;0.51</td><td align="center" rowspan="1" colspan="1">36.06&#x000b1;0.82<xref ref-type="table-fn" rid="t003fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">36.18&#x000b1;0.69</td><td align="center" rowspan="1" colspan="1">-02.49%</td><td align="left" rowspan="1" colspan="1"><bold><italic>F = 16</italic>.<italic>76</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>2</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HR</bold> (bpm)</td><td align="center" rowspan="1" colspan="1">85.11&#x000b1;10.6</td><td align="center" rowspan="1" colspan="1">70.78&#x000b1;9.64<xref ref-type="table-fn" rid="t003fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">69.78&#x000b1;9.74</td><td align="center" rowspan="1" colspan="1">-16.60%</td><td align="left" rowspan="1" colspan="1"><bold><italic>F = 23</italic>.<italic>63</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>2</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>SBP</bold> (mmHg)</td><td align="center" rowspan="1" colspan="1">13.67&#x000b1;0.35</td><td align="center" rowspan="1" colspan="1">11.59&#x000b1;0.37<xref ref-type="table-fn" rid="t003fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">12.16&#x000b1;0.90</td><td align="center" rowspan="1" colspan="1">-15.16%</td><td align="left" rowspan="1" colspan="1"><bold><italic>F = 36</italic>.<italic>67</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>5</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>GLC</bold> (mmol/l)</td><td align="center" rowspan="1" colspan="1">05.05&#x000b1;0.59</td><td align="center" rowspan="1" colspan="1">04.80&#x000b1;0.41</td><td align="center" rowspan="1" colspan="1">04.88&#x000b1;0.48</td><td align="center" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">F = 1.24, p&#x0003e;0.05, &#x003b7;p2 = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>CRE</bold> (&#x003bc;mol/l)</td><td align="center" rowspan="1" colspan="1">83.67&#x000b1;9.43</td><td align="center" rowspan="1" colspan="1">82.11&#x000b1;8.75</td><td align="center" rowspan="1" colspan="1">83.44&#x000b1;9.18</td><td align="center" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">F = 0.73, p&#x0003e;0.05, &#x003b7;p2 = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>WBC</bold> (10<sup>3</sup> /&#x003bc;l)</td><td align="center" rowspan="1" colspan="1">07.52&#x000b1;2.03</td><td align="center" rowspan="1" colspan="1">08.36&#x000b1;2.19<xref ref-type="table-fn" rid="t003fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">08.17&#x000b1;2.25</td><td align="center" rowspan="1" colspan="1">+11.42%</td><td align="left" rowspan="1" colspan="1"><bold><italic>F = 4</italic>.<italic>99</italic>, <italic>p&#x0003c;0</italic>.<italic>05</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>6</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>NEU</bold> (10<sup>3</sup> /&#x003bc;l)</td><td align="center" rowspan="1" colspan="1">04.87&#x000b1;1.86</td><td align="center" rowspan="1" colspan="1">04.83&#x000b1;1.90</td><td align="center" rowspan="1" colspan="1">05.19&#x000b1;1.68</td><td align="center" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">F = 2.67, p&#x0003e;0.05, &#x003b7;p2 = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>RBC</bold> (10<sup>6</sup> / &#x003bc;l)</td><td align="center" rowspan="1" colspan="1">05.43&#x000b1;0.41</td><td align="center" rowspan="1" colspan="1">05.51&#x000b1;0.59</td><td align="center" rowspan="1" colspan="1">05.73&#x000b1;0.63</td><td align="center" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">F = 1.85, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PLT</bold> (10<sup>3</sup> /&#x003bc;l)</td><td align="center" rowspan="1" colspan="1">200.3&#x000b1;42. 9</td><td align="center" rowspan="1" colspan="1">184.1&#x000b1;43.6</td><td align="center" rowspan="1" colspan="1">181.9&#x000b1;46.0</td><td align="center" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">F = 1.68, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>CK</bold> (UI/L)</td><td align="center" rowspan="1" colspan="1">440.3&#x000b1;56.2</td><td align="center" rowspan="1" colspan="1">262.1&#x000b1;19.6<xref ref-type="table-fn" rid="t003fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">237.4&#x000b1;36.5</td><td align="center" rowspan="1" colspan="1">-35.32%</td><td align="left" rowspan="1" colspan="1"><bold><italic>F = 17</italic>.<italic>1 p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>4</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>LDH</bold> (U/l)</td><td align="center" rowspan="1" colspan="1">198.3&#x000b1;43.9</td><td align="center" rowspan="1" colspan="1">156.0&#x000b1;23.3<xref ref-type="table-fn" rid="t003fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">145.3&#x000b1;18.2</td><td align="center" rowspan="1" colspan="1">-20.27%</td><td align="left" rowspan="1" colspan="1"><bold><italic>F = 19</italic>.<italic>8</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>4</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>ASAT</bold> (UI/L)</td><td align="center" rowspan="1" colspan="1">30.44&#x000b1;9.33</td><td align="center" rowspan="1" colspan="1">23.33&#x000b1;5.29<xref ref-type="table-fn" rid="t003fn002"><sup><bold>A</bold></sup></xref></td><td align="center" rowspan="1" colspan="1">20.11&#x000b1;3.82</td><td align="center" rowspan="1" colspan="1">-21.47%</td><td align="left" rowspan="1" colspan="1"><bold><italic>F = 11</italic>.<italic>5</italic>, <italic>p&#x0003c;0</italic>.<italic>001</italic>, <italic>&#x003b7;p</italic></bold><sup><bold><italic>2</italic></bold></sup>
<bold><italic>= 0</italic>.<italic>3</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PAL</bold> (UI/L)</td><td align="center" rowspan="1" colspan="1">75.76&#x000b1;14.1</td><td align="center" rowspan="1" colspan="1">72.78&#x000b1;16.4</td><td align="center" rowspan="1" colspan="1">73.22&#x000b1;16.0</td><td align="center" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">F = 2.81, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>CRP</bold> (mg/l)</td><td align="left" rowspan="1" colspan="1">01.48&#x000b1;0.91</td><td align="left" rowspan="1" colspan="1">01.30&#x000b1;0.88</td><td align="left" rowspan="1" colspan="1">01.24&#x000b1;0.70</td><td align="center" rowspan="1" colspan="1">NS</td><td align="left" rowspan="1" colspan="1">F = 2.69, p&#x0003e;0.05, &#x003b7;p<sup>2</sup> = 0.1</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Temperature, Heart rate (HR), Systolic blood pressure (SBP), Blood Glucose (GLC), Creatinine (CRE), White blood cells (WBC), Neutrophils (NEU), Red blood cells (RBC), Platelets (PLT), Creatinine kinase (CK), Lactate dehydrogenase (LDH), Aspartate aminotransferase (ASAT), Alkaline phosphate (PAL) and C-reactive protein (CRP) represented as mean &#x000b1; <inline-formula id="pone.0160305.e003"><alternatives><graphic id="pone.0160305.e003g" xlink:href="pone.0160305.e003"/><mml:math id="M3"><mml:msub><mml:mi mathvariant="normal">S</mml:mi><mml:mover accent="true"><mml:mi mathvariant="normal">x</mml:mi><mml:mo>&#x000af;</mml:mo></mml:mover></mml:msub></mml:math></alternatives></inline-formula> at rest, 3min and 48h post training session using PLA supplementations.</p></fn><fn id="t003fn002"><p><sup>A</sup> Significant differences between 48h and 3min post training session.; <italic>NB: 3&#x02019; Post training correspond to blood sample 1, 48h recovery correspond to blood sample 2 and rest correspond to blood sample 6 <xref ref-type="fig" rid="pone.0160305.g001">Fig 1</xref></italic></p></fn></table-wrap-foot></table-wrap></sec><sec id="sec028"><title>Recovery kinetic of core temperature, heart rate, systolic blood pressure, glucose and creatinine</title><p>In both conditions (i.e., PLA and POMj), statistical analysis showed a significant decrease (p&#x0003c;0.001) from 3min to 48h after training sessions for oral temperature, HR and SBP with higher rate of decrease for SBP during POMj condition (7.97&#x000b1;1.52%). However, for GLC and CRE no significant changes were registered during the two conditions. For all these parameters (i.e., temperature, HR, SBP, GLC and CRE) and in both conditions, 48h of recovery was a sufficient period to return the post-training values (3min) to the resting levels.</p></sec><sec id="sec029"><title>Recovery kinetic of hematological parameters</title><p>Concerning the hematological parameters, WBC values showed a significant difference between 3min (post training) and 48h recovery values in both conditions with higher values after 48h (p&#x0003c;0.05, rate of increase = +10.82&#x000b1;2.99% using PLA and rate of increase = +11.42&#x000b1;3.68% using POMj). Moreover, there is a significant decrease of PLT between 3min (post training) and 48h recovery values only during PLA condition with lower values after the 48h recovery period (p&#x0003c;0.05, rate of decrease = -16.07&#x000b1;2.65%). However, for NEU and RBC no significant differences were observed during recovery in both conditions. For all the hematological parameters, 48h of recovery period was sufficient in both conditions to return the post-training values (3min) to the rest levels.</p></sec></sec><sec id="sec030"><title>Recovery kinetic of muscle damage parameters and c-reactive proteinCRP</title><p>For the muscle damage and inflammatory parameters, significant decreases from 3min to 48h after training session were registered during both PLA and POMj conditions for CK (p&#x0003c;0.01 and p&#x0003c;0.001), LDH (p&#x0003c;0.01 and p&#x0003c;0.001) and ASAT (p&#x0003c;0.05 and p&#x0003c;0.01) with higher rates of decreases (11.34&#x000b1;1.98%, 7.30&#x000b1;0.86% and 6.77&#x000b1;0.47%) using POMj. For these parameters, the 48h period was sufficient to recover the resting values only using POMj supplementation. In fact, during PLA condition, these parameters showed a significant difference between 48h recovery and rest values (p&#x0003c;0.01 for CK, ASAT and LDH). For PAL and CRP, no significant alterations were registered in both conditions.</p></sec></sec><sec sec-type="conclusions" id="sec031"><title>Discussion</title><p>The aim of this study was to investigate the effect of natural POMj supplementation on weightlifting performance, perception of muscle fatigue and soreness as well as the acute and delayed biochemical responses following a morning weightlifting training session. The main results showed that, comparing to PLA, the consumption of POMj 48h before and during the training session (i) ameliorated the total (+8.3%) and the maximal (+3.26%) lifted amount in the two Olympic movements and (ii) improved the perception of muscle fatigue (4.37%) immediately and the perception of the knee extensors muscle soreness (13.4%) 48h after the training session. Moreover, POMj modified the kinetic of the acute and delayed biological responses with a reduction in the immediate increase of the HR (-4.46%), SBP (-1.81%), CK (-8.75%) and LDH (-1.64%), an absence of significant increase of ASAT, PAL and CRP three min after the training session and an improvement in the delayed recovery kinetic of SBP, CK, LDH and ASAT (7.97%, 11.34%, 7.30% and 6.77%, respectively).</p><sec id="sec032"><title>Effect of pomegranate supplementation on the calculated performances</title><p>The total and the maximal amount raised in the two Olympic lifts (i.e. the Snatch and Clean&#x00026; Jerk) during the training session were higher in POMj condition compared to PLA. These results suggest that POMj supplementation during the weightlifting training session and during the 48h that proceeds, improve the whole body muscle strength and ameliorate the capacity to adhere to intense training program. This study confirms the results of Trombold et al. [<xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>], which showed that a daily drink of 0.5L POMj for five days prior to intense exercise improved the strength recovery 2&#x02013;3 days after damaging eccentric exercise. In this sense, Machin et al. [<xref rid="pone.0160305.ref021" ref-type="bibr">21</xref>] showed that both once-daily (650&#x02009;mg/d) and twice daily (1,300&#x02009;mg&#x02009;/d) dietary polyphenol supplementation improves strength recovery of both leg and arm muscles after unaccustomed eccentric exercise. Similarly, Trombold et al. [<xref rid="pone.0160305.ref003" ref-type="bibr">3</xref>] have found that POMj ingested before the eccentric exercise and through the recovery period improved the arm strength (i.e., immediately (8&#x02013;10%) and during the 2h to 168h period post exercise) and have no effect on the knee isometric strength. The present study results confirms these previous findings upon the potential effects of POMj on strength performances of the whole body muscles, as Olympic weightlifting exercises involve the majorities of human muscles [<xref rid="pone.0160305.ref035" ref-type="bibr">35</xref>].</p></sec><sec id="sec033"><title>Effect of pomegranate on the acute and delayed muscle fatigue and soreness</title><p>In this study, significant effects of POMj supplementation were shown for RPE and for the DOMS of the knee extensors with lower values immediately and 48h after the corresponding training session. The present results of RPE were in line with the results of Trombold et al. [<xref rid="pone.0160305.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>] showing that, in both untrained and trained subjects, a daily drink of POMj prior to intense eccentric exercise and during recovery improves the muscle soreness at 120 min after exercise. The lower levels of muscle fatigue and soreness felt immediately after exercises when using POMj (i) could be explained by a lower level of tissue oedema and/or a lower accumulation of metabolic by-products [<xref rid="pone.0160305.ref036" ref-type="bibr">36</xref>] and (ii) indicates that during the corresponding exercises, athletes felt less fatigable, and this can explain their better performance [<xref rid="pone.0160305.ref003" ref-type="bibr">3</xref>]. Concerning the recovery of muscle soreness in the 48h following the training session, the present findings showed a significant improvement using the POMj only in the soreness of knee extensors muscles but not in the elbow flexors. These results are in contradiction with those of Trombold et al. [<xref rid="pone.0160305.ref003" ref-type="bibr">3</xref>] who showed that POMj aid in the recovery of soreness only in the arm muscles but not in the leg muscles. The present absence of significant POMj effects on the delayed soreness of the elbow flexors could be explained by the fact that in both PLA and POMj conditions, weightlifting training exercises induced more soreness (+40&#x000b1;3%) in the leg muscles compared to the arm ones. The presence of a significant effect of POMj on the DOMS of the knee extensors in the present study, which was absent in the study of Trombold et al. [<xref rid="pone.0160305.ref003" ref-type="bibr">3</xref>], could be explained by the higher dose of Ployphenol in the present POMj (i.e., natural POMj contains 2.56g/500ml while the commercialized one contains only 650 mg/480ml).</p><p>Comparing the present effects of natural POMj with previous nutritional interventions (vitamins, anti-inflammatory etc), it seems that POMj has a powerful effect in improving muscle performance and reducing DOMS. Nevertheless, using vitamin supplementations (C or E), showed no influence on soreness or strength performance [<xref rid="pone.0160305.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0160305.ref038" ref-type="bibr">38</xref>]. Similarly, non-steroidal anti-inflammatory drug (<italic>NSAID</italic>) supplementation shows the improvement of soreness but has no effect on strength levels [<xref rid="pone.0160305.ref039" ref-type="bibr">39</xref>]. Ingestion of combination of ascorbic acid, &#x003b1;-tocopherol, and selenium [<xref rid="pone.0160305.ref040" ref-type="bibr">40</xref>] or mixture of tocopherols, flavonoids (i.e., Hesperetin and quercetin), selenium or docosahexaenoate [<xref rid="pone.0160305.ref041" ref-type="bibr">41</xref>] have been reported to reduce oxidative stress after eccentric exercise and to attenuate systematic (CRP and interleukin6) inflammation markers, respectively. However, strength performance and DOMS were not recorded in both studies. Therefore, POMj could be an effective treatment to improve the recovery of muscles&#x02019; strength and reduce fatigue and weakness. On the other hand, it was suggested that delayed soreness is associated with the inflammatory and muscle damage responses [<xref rid="pone.0160305.ref036" ref-type="bibr">36</xref>]. The present study confirms this suggestion and shows a higher correlation between DOMS (i.e. leg extensors and elbow flexors) and CK values (r = 0.8 and r = 0.7, respectively).</p></sec><sec id="sec034"><title>Effect of the weightlifting training session on the biological levels</title><p>The present results showed a significant training effect for the majorities of biological studied parameters (i.e., hematological, muscle damage and inflammatory) with higher values of temperature, HR, SBP, CK, LDH, ASAT at post-training session compared to pre-training session in both conditions (i.e., PLA and POMj). These findings are in line with previous studies of Lui et al. [<xref rid="pone.0160305.ref004" ref-type="bibr">4</xref>], Petterson et al. [<xref rid="pone.0160305.ref005" ref-type="bibr">5</xref>] and Ammar et al [<xref rid="pone.0160305.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0160305.ref007" ref-type="bibr">7</xref>] which showed a significant increase of muscle damage and inflammatory marker following weightlifting training sessions.</p></sec><sec id="sec035"><title>Effect of pomegranate on the acute and delayed biological response</title><p>Compared to the PLA condition, natural POMj modifies the acute responses for the majority of the tested parameters. Indeed, during POMj condition, (i) the significant differences pre-post training session were suppressed for WBC, NEU, RBC, ASAT, PAL and CRP, and (ii) a reduction in the rate of increase (pre-post training session) were shown for HR, SBP and the muscle damage parameters (i.e., CK and LDH). Moreover, only using POMj, a significant increase in CRE and a significant decrease in GLC were shown, indicating a higher GLC consumption and CRE production during the corresponding session. The above-mentioned physiological modifications using POMj could be in the origin of the better physical performances and lower fatigue perception observed in the second test session. Concerning the delayed effect, the present results showed that the consumption of POMj during the 48h of recovery period, accelerate the recovery kinetic of SBP, CK and LDH and increase the PLT level. The lower SBP level registered using the POMj supplementation confirms the previous result of Aviram et al. [<xref rid="pone.0160305.ref009" ref-type="bibr">9</xref>] who showed a reduction of high systolic blood pressure by 12% after a daily drink of 500ml of POMj. The significant delayed increase of the PLT levels using POMj suggests that POMj supplementation could be also an effective treatment for patients who suffer from the thrombocytopenia disease (i.e., disorder in which there is an abnormally low amount of platelets sometimes associated with abnormal bleeding [<xref rid="pone.0160305.ref042" ref-type="bibr">42</xref>]). However, confirming this suggestion using patients with thrombocytopenia disease is necessary. Moreover, the acute increase in CRP level only during PLA condition confirms previous findings [<xref rid="pone.0160305.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0160305.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0160305.ref015" ref-type="bibr">15</xref>] indicating that fermented pomegranate polyphenols have an anti-inflammatory effect explained by an inhibition of some inflammatory markers such as NF-&#x003ba;-B, TNF&#x003b1; and COX-2. However, the present findings are in contradiction with those of Trombold et al. [<xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>] who showed that a daily drink of 500ml POMj prior exercise for 5 days has no effect on the levels of inflammation (i.e., interleukin-6 and CRP) and muscle damage (i.e., CK and myoglobin). These contradictory results could be explained by the training levels of the participants and the daily dose of POMj. In fact, Trombold et al. [<xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>] investigated untrained subjects while the present participants were elite weightlifters. Moreover, the present study dose of POMj was 250ml higher than the one of Trombold et al. [<xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>]. Thus, authors speculate that a 750ml (3 &#x000d7; 250ml) daily drink of POMj could be an optimal dose to have a significant anti-inflammatory effect. Additionally, the present effect of POMj&#x02013;which consists in a potent antioxidant supplementation [<xref rid="pone.0160305.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="pone.0160305.ref010" ref-type="bibr">10</xref>]&#x02014;in reducing the acute and delayed muscle damage and inflammatory responses, suggests a strong relation between the muscle damage, inflammatory and oxidative process. This suggestion is in line with previous studies of (i) Lui et al. [<xref rid="pone.0160305.ref004" ref-type="bibr">4</xref>] who showed a significant correlation between the malondialdehyde (MDA) and the CK, WBC and NEU, (ii) Cudney et al. [<xref rid="pone.0160305.ref043" ref-type="bibr">43</xref>] who suggested that lipid peroxidation could be in the origin of hematological and muscle damage alteration, and (iii) Tidball et al. [<xref rid="pone.0160305.ref044" ref-type="bibr">44</xref>] who suggested a causal relation between inflammatory responses and generalized muscle damage after strenuous exercise.</p></sec><sec id="sec036"><title>Effect of pomegranate on the recovery kinetic of the biological parameters</title><p>Concerning the effect of 48h recovery period associated to PLA or POMj supplementations, the present results showed that this period was sufficient to recover the baseline levels of HR, SBP, GLC, CRE, PAL, CRP and all the hematological parameters, whereas, CK, LDH and ASAT remained elevated. These results confirm previous results of Ammar et al. [<xref rid="pone.0160305.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0160305.ref007" ref-type="bibr">7</xref>] who showed that 48h recovery period decreases significantly the CRP values and the majority of muscle damages markers compared to post-training session; but was not sufficient to recover the resting values of CK, LDH and ASAT. Likewise, the present study shows that using POMj supplementation during the recovery period helps in returning the post-training session values of CK, LDH and ASAT to their baseline concentrations. These results were especially due to the higher rate of decrease (i.e., 3min to 48h post training session) following the consumption of POMj supplement compared to the PLA. Indeed, the results showed that the rates of decrease were 11.34%, 7.30% and 6.77% higher respectively for CK, LDH and ASAT, using POMj supplementation. Similarly, with the same condition, the CRP showed higher rate of decrease (5.1%) during the 48h period. The present acceleration in the recovery kinetic of CK, LDH, ASAT and CRP, affirms the above-mentioned suggestion that pomegranate could be a potent anti-inflammatory and anti-damage treatment. In this context, it has been also found that polyphenol possess a high biological activity during stressed or pathological situation (i.e., characterized by higher inflammatory and oxidative levels) [<xref rid="pone.0160305.ref016" ref-type="bibr">16</xref>] and have also cardio-, cancer, atherosclerosis and rheumatoid arthritis protective effects [<xref rid="pone.0160305.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0160305.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0160305.ref013" ref-type="bibr">13</xref>].</p><p>The efficacy of POMj could be attributed to its high content of polyphenols. Indeed, using POM Wonderful bottle (Los Angeles, CA, with total polyphenol content of 650 mg in each 480-ml bottle [<xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>]), has no reported effect on muscle damage levels. However, in the present study, using natural POMj -that contains 2.56g of polyphenol in each 500ml- showed an acceleration of muscle damage recovery following intense weightlifting training session.</p><p>Furthermore, using similar training session at different times of the day, Ammar et al. [<xref rid="pone.0160305.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0160305.ref007" ref-type="bibr">7</xref>] showed that performance (i.e, total lifted amount) was lower in the morning compared to the evening (i.e., range of -8.30 &#x000b1; 3.02%), with higher RPE (+4.78&#x000b1;1.67%) and muscle damage levels at this time of day (TOD). The present results showed that using POMj supplementation, the morning performance (i.e., total lifted amount) and RPE values were improved by 8.29&#x000b1;3.8% and 4.37&#x000b1;1.45%, respectively and the muscle damage levels were decreased. Therefore, the authors suggest that the POMj consumption through the recovery period and during morning training could counteract the lower morning performance and the higher fatigability at this TOD. However, more studies include training session in different TOD associated to POMj supplementation are necessary to confirm these suggestions.</p></sec><sec id="sec037"><title>Methodological considerations</title><p>Previous double-blind-randomized study which investigate the effect of POMj consumption on strength recovery have shown that 14-days could be a sufficient &#x0201c;wash-out&#x0201d; period for POMj [<xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>]. Indeed, in relation with strength recovery assessment, Trombold et al. [<xref rid="pone.0160305.ref020" ref-type="bibr">20</xref>] reported no significant differences between trial 1 PLA and trial 2 PLA and between trial 1 POM and trial 2 POM, when ordering effects are assessed dependent of the treatment. However, in another study, the antioxidant beneficial effects of the POMj have shown to persist up to 3 weeks after consumption was halted [<xref rid="pone.0160305.ref028" ref-type="bibr">28</xref>]. These findings speculate that beneficial effect of POMj on both oxidative stress and muscle damages could persist for up to 3 weeks. Based on the above results, the authors of the present study preferred to not randomize the treatment-with POMj as second treatment-in the study of anti-damaging effects of POMj following intensive exercise with short wash-out period (e.g., 48h, especially using people required to work intensely every 2&#x02013;3 d). A limitation of this study was that, having the POMj trial always second might have biased the results. Indeed, it is possible that the first control bout (i.e., PLA) offered the participants some level of protection from DOMS during the second bout (i.e., POMj) [<xref rid="pone.0160305.ref045" ref-type="bibr">45</xref>]. However, given that this experimental design was not a separate training where the body will adapt in each session; the order effect seems to be minimal.</p></sec></sec><sec sec-type="conclusions" id="sec038"><title>Conclusion</title><p>The present study showed that consuming POMj supplementation&#x02013;in 9 elites athletes- during weightlifting training session and during the 48h before (i), reduce the acuteness of the pain and delayed responses of the muscle damage and inflammation, and muscle soreness (i.e., knee flexor) (ii) accelerate the recovery kinetic of the biological parameters and (iii) improve the weightlifting performance. However, given the small sample size, further studies should verify these results using greater sample of athletes.</p></sec><sec sec-type="supplementary-material" id="sec039"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0160305.s001"><label>S1 Individual Data Points</label><caption><title>Individual data points.</title><p>(DOCX)</p></caption><media xlink:href="pone.0160305.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0160305.s002"><label>S1 Protocol</label><caption><title>Study Protocol.</title><p>(DOCX)</p></caption><media xlink:href="pone.0160305.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0160305.s003"><label>S1 Receipt of the Trial Registry</label><caption><title>Receipt of the trial registry ((ClinicalTrials.gov PRS).</title><p>(PDF)</p></caption><media xlink:href="pone.0160305.s003.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0160305.s004"><label>S1 TREND Checklist</label><caption><title>Trend Statement Checklist.</title><p>(PDF)</p></caption><media xlink:href="pone.0160305.s004.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors wish to thank all the participants for their maximal effort and cooperation.</p><p>The authors report no funding source for this work.</p></ack><ref-list><title>References</title><ref id="pone.0160305.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Gibala</surname><given-names>MJ</given-names></name>, <name><surname>MacDougall</surname><given-names>JD</given-names></name>, <name><surname>Tarnopolsky</surname><given-names>MA</given-names></name>, <name><surname>Stauber</surname><given-names>WT</given-names></name>, <name><surname>Elorriaga</surname><given-names>A</given-names></name>. <article-title>Changes in human skeletal muscle ultrastructure and force production after acute resistance exercise</article-title>. <source>J Appl Physiol</source>. <year>1995</year>; <volume>78</volume>(<issue>2</issue>):<fpage>702</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">7759443</pub-id></mixed-citation></ref><ref id="pone.0160305.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Sousa</surname><given-names>M</given-names></name>, <name><surname>Teixeira</surname><given-names>VH</given-names></name>, <name><surname>Soares</surname><given-names>J</given-names></name>. <article-title>Dietary strategies to recover from exercise-induced muscle damage</article-title>. <source>Int J Food Sci Nutr</source>. <year>2014</year>; <volume>65</volume>(<issue>2</issue>):<fpage>151</fpage>&#x02013;<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3109/09637486.2013.849662">10.3109/09637486.2013. 849662</ext-link></comment>
<pub-id pub-id-type="pmid">24180469</pub-id></mixed-citation></ref><ref id="pone.0160305.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Trombold</surname><given-names>JR</given-names></name>, <name><surname>Reinfeld</surname><given-names>AS</given-names></name>, <name><surname>Casler</surname><given-names>JR</given-names></name>, <name><surname>Coyle</surname><given-names>EF</given-names></name>. <article-title>The effect of pomegranate juice supplementation on strength and soreness after eccentric exercise</article-title>. <source>J Strength Cond Res</source>. <year>2011</year>; <volume>25</volume>(<issue>7</issue>):<fpage>1782</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1519/JSC.0b013e318220d992">10.1519/JSC.0b013e318220d992</ext-link></comment>
<pub-id pub-id-type="pmid">21659887</pub-id></mixed-citation></ref><ref id="pone.0160305.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>JF</given-names></name>, <name><surname>Chang</surname><given-names>WY</given-names></name>, <name><surname>Chan</surname><given-names>KH</given-names></name>, <name><surname>Tsai</surname><given-names>WY</given-names></name>, <name><surname>Lin</surname><given-names>CL</given-names></name>, <name><surname>Hsu</surname><given-names>MC</given-names></name>. <article-title>Blood lipid peroxides and muscle damage increased following intensive resistance training of female weightlifters</article-title>. <source>Ann N Y Acad Sci</source>. <year>2005</year>; <volume>1042</volume>: <fpage>255</fpage>&#x02013;<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1196/annals.1338.029">10.1196/annals.1338.029</ext-link></comment>
<pub-id pub-id-type="pmid">15965070</pub-id></mixed-citation></ref><ref id="pone.0160305.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Pettersson</surname><given-names>J</given-names></name>, <name><surname>Hindorf</surname><given-names>U</given-names></name>, <name><surname>Persson</surname><given-names>P</given-names></name>, <name><surname>Bengtsson</surname><given-names>T</given-names></name>, <name><surname>Malmqvist</surname><given-names>U</given-names></name>, <name><surname>Werkstr&#x000f6;m</surname><given-names>V</given-names></name>
<etal>et al</etal>
<article-title>Muscular exercise can cause highly pathological liver function tests in healthy men</article-title>. <source>Br J Clin Pharmacol</source>. <year>2008</year>; <volume>65</volume>: <fpage>253</fpage>&#x02013;<lpage>259</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2125.2007.03001.x">10.1111/j.1365-2125.2007.03001.x</ext-link></comment>
<pub-id pub-id-type="pmid">17764474</pub-id></mixed-citation></ref><ref id="pone.0160305.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Ammar</surname><given-names>A</given-names></name>, <name><surname>Chtourou</surname><given-names>H</given-names></name>, <name><surname>Trabelsi</surname><given-names>K</given-names></name>, <name><surname>Padulo</surname><given-names>J</given-names></name>, <name><surname>Turki</surname><given-names>M</given-names></name>, <name><surname>El Abed</surname><given-names>K</given-names></name>
<etal>et al</etal>
<article-title>Temporal specificity of training: intra-day effects on biochemical responses and Olympic-Weightlifting performances</article-title>. <source>J Sports Sci</source>. <year>2014</year>; <volume>33</volume>(<issue>4</issue>):<fpage>358</fpage>&#x02013;<lpage>68</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/02640414.2014.944559">10.1080/02640414.2014.944559</ext-link></comment>
<pub-id pub-id-type="pmid">25117722</pub-id></mixed-citation></ref><ref id="pone.0160305.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Ammar</surname><given-names>A</given-names></name>, <name><surname>Chtourou</surname><given-names>H</given-names></name>, <name><surname>Hammouda</surname><given-names>O</given-names></name>, <name><surname>Trabelsi</surname><given-names>K</given-names></name>, <name><surname>Chiboub</surname><given-names>J</given-names></name>, <name><surname>Turki</surname><given-names>M</given-names></name>, <name><surname>AbdelKarim</surname><given-names>O</given-names></name>, <name><surname>El Abed</surname><given-names>K</given-names></name>, <name><surname>Ben Ali</surname><given-names>M</given-names></name>, <name><surname>Hoekelmann</surname><given-names>A</given-names></name>, <name><surname>Souissi</surname><given-names>N</given-names></name>. <article-title>Acute and delayed responses of C-reactive protein, malondialdehyde and antioxidant markers after resistance training session in elite weightlifters: Effect of Time of day</article-title>. <source>Chronobiol Int</source>. <year>2015</year>; <volume>32</volume>(<issue>9</issue>):<fpage>1211</fpage>&#x02013;<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3109/07420528.2015.1079215">10.3109/07420528.2015.1079215</ext-link></comment>
<pub-id pub-id-type="pmid">26453313</pub-id></mixed-citation></ref><ref id="pone.0160305.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Afaq</surname><given-names>F</given-names></name>, <name><surname>Saleem</surname><given-names>M</given-names></name>, <name><surname>Krueger</surname><given-names>CG</given-names></name>, <name><surname>Reed</surname><given-names>JD</given-names></name>, <name><surname>Mukhtar</surname><given-names>H</given-names></name>. <article-title>Anthocyanin- and hydrolysable tannin-rich pomegranate fruit extract modulates MAPK and NF-&#x003ba;Bpathways and inhibits skin tumorigenesis in CD-1 mice.</article-title>
<source>Int J Cancer</source>. <year>2005</year>; <volume>113</volume>:<fpage>423</fpage>&#x02013;<lpage>33</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ijc.20587">10.1002/ijc.20587</ext-link></comment>
<pub-id pub-id-type="pmid">15455341</pub-id></mixed-citation></ref><ref id="pone.0160305.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Aviram</surname><given-names>M</given-names></name>, <name><surname>Rosenblat</surname><given-names>M</given-names></name>, <name><surname>Gaitini</surname><given-names>D</given-names></name>, <name><surname>Nitecki</surname><given-names>S</given-names></name>, <name><surname>Hoffman</surname><given-names>A</given-names></name>, <name><surname>Dornfeld</surname><given-names>L</given-names></name>
<etal>et al</etal>
<article-title>Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation</article-title>. <source>Clin Nutr</source>. <year>2004</year>; <volume>23</volume>(<issue>3</issue>):<fpage>423</fpage>&#x02013;<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.clnu.2003.10.002">10.1016/j.clnu.2003.10.002</ext-link></comment>
<pub-id pub-id-type="pmid">15158307</pub-id></mixed-citation></ref><ref id="pone.0160305.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Zarfeshany</surname><given-names>A</given-names></name>, <name><surname>Asgary</surname><given-names>S</given-names></name>, <name><surname>Javanmard</surname><given-names>SH</given-names></name>. <article-title>Potent health effects of pomegranate</article-title>. <source>Adv Biomed Res</source>. <year>2014</year>; <volume>3</volume>:<fpage>100</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4103/2277-9175.129371">10.4103/2277-9175.129371</ext-link></comment>
<pub-id pub-id-type="pmid">24800189</pub-id></mixed-citation></ref><ref id="pone.0160305.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Kelawala</surname><given-names>NS</given-names></name>, <name><surname>Ananthanarayan</surname><given-names>L</given-names></name>. <article-title>Antioxidant activity of selected foodstuffs</article-title>. <source>Int J Food Sci Nutr</source>. <year>2004</year>; <volume>55</volume>(<issue>6</issue>):<fpage>511</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/09637480400015794">10.1080/09637480400015794</ext-link></comment>
<pub-id pub-id-type="pmid">15762315</pub-id></mixed-citation></ref><ref id="pone.0160305.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Aviram</surname><given-names>M</given-names></name>, <name><surname>Dornfeld</surname><given-names>L</given-names></name>, <name><surname>Kaplan</surname><given-names>M</given-names></name>, <name><surname>Coleman</surname><given-names>R</given-names></name>, <name><surname>Gaitini</surname><given-names>D</given-names></name>, <name><surname>Nitecki</surname><given-names>S</given-names></name>
<etal>et al</etal>
<article-title>Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans</article-title>. <source>Drugs Exp Clin Res</source>. <year>2002</year>; <volume>28</volume>(<issue>2&#x02013;3</issue>):<fpage>49</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="pmid">12224378</pub-id></mixed-citation></ref><ref id="pone.0160305.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Sumner</surname><given-names>MD</given-names></name>, <name><surname>Elliott-Eller</surname><given-names>M</given-names></name>, <name><surname>Weidner</surname><given-names>G</given-names></name>, <name><surname>Daubenmier</surname><given-names>JJ</given-names></name>, <name><surname>Chew</surname><given-names>MH</given-names></name>, <name><surname>Marlin</surname><given-names>R</given-names></name>
<etal>et al</etal>
<article-title>Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease</article-title>. <source>Am J Cardiol</source>. <year>2005</year>; <volume>96</volume>(<issue>6</issue>):<fpage>810</fpage>&#x02013;<lpage>4</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2005.05.026">10.1016/j.amjcard.2005.05.026</ext-link></comment>
<pub-id pub-id-type="pmid">16169367</pub-id></mixed-citation></ref><ref id="pone.0160305.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Afaq</surname><given-names>F</given-names></name>, <name><surname>Malik</surname><given-names>A</given-names></name>, <name><surname>Syed</surname><given-names>D</given-names></name>, <name><surname>Maes</surname><given-names>D</given-names></name>, <name><surname>Matsui</surname><given-names>MS</given-names></name>, <name><surname>Mukhtar</surname><given-names>H</given-names></name>. <article-title>Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and ac-tivation of nuclear factor kappaB in normal human epidermal keratinocytes paragraph sign</article-title>. <source>Photochemistry and Photobiology</source>. <year>2005</year>; <volume>81</volume>: <fpage>38</fpage>&#x02013;<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1562/2004-08-06-RA-264">10.1562/2004-08-06-RA-264</ext-link></comment>
<pub-id pub-id-type="pmid">15493960</pub-id></mixed-citation></ref><ref id="pone.0160305.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>TH</given-names></name>, <name><surname>Yang</surname><given-names>Q</given-names></name>, <name><surname>Harada</surname><given-names>M</given-names></name>, <name><surname>Li</surname><given-names>GQ</given-names></name>, <name><surname>Yamahara</surname><given-names>J</given-names></name>, <name><surname>Roufogalis</surname><given-names>BD</given-names></name>
<etal>et al</etal>
<article-title>Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB path-ways</article-title>. <source>J Cardiovasc Pharmacol</source>. <year>2005</year>; <volume>46</volume>: <fpage>856</fpage>&#x02013;<lpage>862</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/01.fjc.0000190489.85058.7e">10.1097/01.fjc.0000190489.85058.7e</ext-link></comment>
<pub-id pub-id-type="pmid">16306813</pub-id></mixed-citation></ref><ref id="pone.0160305.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Shukla</surname><given-names>M</given-names></name>, <name><surname>Gupta</surname><given-names>K</given-names></name>, <name><surname>Rasheed</surname><given-names>Z</given-names></name>, <name><surname>Khan</surname><given-names>KA</given-names></name>, <name><surname>Haqqi</surname><given-names>TM</given-names></name>. <article-title>Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis</article-title>. <source>Nutrition</source>. <year>2008</year>; <volume>24</volume>(<issue>7&#x02013;8</issue>):<fpage>733</fpage>&#x02013;<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.nut.2008.03.013">10.1016/j.nut.2008.03.013</ext-link></comment>
<pub-id pub-id-type="pmid">18490140</pub-id></mixed-citation></ref><ref id="pone.0160305.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Azadzoi</surname><given-names>KM</given-names></name>, <name><surname>Schulman</surname><given-names>RN</given-names></name>, <name><surname>Aviram</surname><given-names>M</given-names></name>, <name><surname>Siroky</surname><given-names>MB</given-names></name>. <article-title>Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants</article-title>. <source>J Urol</source>. <year>2005</year>; <volume>174</volume>: <fpage>386</fpage>&#x02013;<lpage>393</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/01.ju.0000161209.39959.67">10.1097/01.ju.0000161209.39959.67</ext-link></comment>
<pub-id pub-id-type="pmid">15947695</pub-id></mixed-citation></ref><ref id="pone.0160305.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Seeram</surname><given-names>NP</given-names></name>, <name><surname>Aviram</surname><given-names>M</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Henning</surname><given-names>SM</given-names></name>, <name><surname>Feng</surname><given-names>L</given-names></name>, <name><surname>Dreher</surname><given-names>M</given-names></name><etal>et al</etal>
<article-title>Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States</article-title>. <source>J Agric Food Chem</source>. <year>2008</year>; <volume>56</volume>(<issue>4</issue>):<fpage>1415</fpage>&#x02013;<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1021/jf073035s">10.1021/jf073035s</ext-link></comment>
<pub-id pub-id-type="pmid">18220345</pub-id></mixed-citation></ref><ref id="pone.0160305.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Polagruto</surname><given-names>JA</given-names></name>, <name><surname>Schramm</surname><given-names>DD</given-names></name>, <name><surname>Wang-Polagruto</surname><given-names>JF</given-names></name>, <name><surname>Lee</surname><given-names>L</given-names></name>, <name><surname>Keen</surname><given-names>CL</given-names></name>. <article-title>Effects of flavonoid-rich beverages on prostacyclin synthesis in humans and human aortic endothelial cells: association with ex vivo platelet function</article-title>. <source>J Med Food</source>. <year>2003</year>; <volume>6</volume>(<issue>4</issue>):<fpage>301</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/109662003772519840">10.1089/109662003772519840</ext-link></comment>
<pub-id pub-id-type="pmid">14977437</pub-id></mixed-citation></ref><ref id="pone.0160305.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Trombold</surname><given-names>JR</given-names></name>, <name><surname>Barnes</surname><given-names>JN</given-names></name>, <name><surname>Critchley</surname><given-names>L</given-names></name>, <name><surname>Coyle</surname><given-names>EF</given-names></name>. <article-title>Ellagitannin consumption improves strength recovery 2&#x02013;3 d after eccentric exercise</article-title>. <source>Med Sci Sports Exerc</source>. <year>2010</year>; <volume>42</volume>(<issue>3</issue>):<fpage>493</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1249/MSS.0b013e3181b64edd">10.1249/MSS.0b013e3181b64edd</ext-link></comment>
<pub-id pub-id-type="pmid">19952825</pub-id></mixed-citation></ref><ref id="pone.0160305.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Machin</surname><given-names>DR</given-names></name>, <name><surname>Christmas</surname><given-names>KM</given-names></name>, <name><surname>Chou</surname><given-names>TH</given-names></name>, <name><surname>Sarah</surname><given-names>CH</given-names></name>, <name><surname>Douglas</surname><given-names>WVP</given-names></name>, <name><surname>Justin</surname><given-names>RT</given-names></name>
<etal>et al</etal>
<article-title>Effects of Differing Dosages of Pomegranate Juice Supplementation after Eccentric Exercise</article-title>. <source>Physiology Journal</source>. <year>2014</year>; ID 271959, <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2014/271959">10.1155/2014/271959</ext-link></comment></mixed-citation></ref><ref id="pone.0160305.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Padulo</surname><given-names>J</given-names></name>, <name><surname>Laffaye</surname><given-names>G</given-names></name>, <name><surname>Chaouachi</surname><given-names>A</given-names></name>, <name><surname>Chamari</surname><given-names>K</given-names></name>. <article-title>Bench press exercise: The key points</article-title>. <source>J Sports Med Phys Fitness</source>. <year>2015</year>; <volume>55</volume>(<issue>6</issue>):<fpage>604</fpage>&#x02013;<lpage>8</lpage>
<pub-id pub-id-type="pmid">24823345</pub-id></mixed-citation></ref><ref id="pone.0160305.ref023"><label>23</label><mixed-citation publication-type="book"><name><surname>Kraemer</surname><given-names>WJ</given-names></name>, <name><surname>Fry</surname><given-names>AC</given-names></name>. <chapter-title>Strength testing: Development and evaluation of methodology</chapter-title> In: <name><surname>Maud</surname><given-names>P</given-names></name>, <name><surname>Foster</surname><given-names>C</given-names></name>, editors. <source>Physiological assessment of human fitness</source>, <publisher-loc>Champaign, IL</publisher-loc>: <publisher-name>Human Kinetics</publisher-name>; <year>1995</year>, p. <fpage>115</fpage>&#x02013;<lpage>138</lpage>.</mixed-citation></ref><ref id="pone.0160305.ref024"><label>24</label><mixed-citation publication-type="other">Borg G. Borg's Perceived Exertion and Pain Scales. In the USA: P.O. Box 5076, Champaign, IL:HK. Can be ordered from: Human Kinetics, Champaign, 1998, IL 61825&#x02013;5076, and in Europe: P.O. Box IW14, Leeds, LS16 6TR, UK.</mixed-citation></ref><ref id="pone.0160305.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Bougard</surname><given-names>C</given-names></name>, <name><surname>Moussay</surname><given-names>S</given-names></name>, <name><surname>Gauthier</surname><given-names>A</given-names></name>, <name><surname>Espi&#x000e9;</surname><given-names>S</given-names></name>, <name><surname>Davenne</surname><given-names>D</given-names></name>. <article-title>Effects of waking time and breakfast intake prior to evaluation of psychomotor performance in the early morning</article-title>. <source>Chronobiol Int</source>. <year>2009</year>; <volume>26</volume>: <fpage>324</fpage>&#x02013;<lpage>336</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/07420520902774540">10.1080/07420520902774540</ext-link></comment>
<pub-id pub-id-type="pmid">19212844</pub-id></mixed-citation></ref><ref id="pone.0160305.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Cribb</surname><given-names>PJ</given-names></name>, <name><surname>Hayes</surname><given-names>A</given-names></name>: <article-title>Effects of supplement timing and resistance exercise on skeletal muscle hypertrophy</article-title>. <source>Med Sci Sports Exer</source>. <year>2006</year>; <volume>38</volume>:<fpage>1918</fpage>&#x02013;<lpage>1925</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1249/01.mss.0000233790.08788.3e">10.1249/01.mss.0000233790.08788.3e</ext-link></comment>
<pub-id pub-id-type="pmid">17095924</pub-id></mixed-citation></ref><ref id="pone.0160305.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Trexler</surname><given-names>ET</given-names></name>, <name><surname>Smith-Ryan</surname><given-names>AE</given-names></name>, <name><surname>Melvin</surname><given-names>MN</given-names></name>, <name><surname>Roelofs</surname><given-names>EJ</given-names></name>, <name><surname>Wingfield</surname><given-names>HL</given-names></name>. <article-title>Effects of pomegranate extract on blood flow and running time to exhaustion</article-title>. <source>Appl Physiol Nutr Metab</source>. <year>2014</year>;<volume>39</volume>(<issue>9</issue>):<fpage>1038</fpage>&#x02013;<lpage>42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1139/apnm-2014-0137">10.1139/apnm-2014-0137</ext-link></comment>
<pub-id pub-id-type="pmid">25051173</pub-id></mixed-citation></ref><ref id="pone.0160305.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Matthaiou</surname><given-names>CM</given-names></name>, <name><surname>Goutzourelas</surname><given-names>N</given-names></name>, <name><surname>Stagos</surname><given-names>D</given-names></name>, <name><surname>Sarafoglou</surname><given-names>E</given-names></name>, <name><surname>Jamurtas</surname><given-names>A</given-names></name>, <name><surname>Koulocheri</surname><given-names>SD</given-names></name>, <etal>et al</etal>
<article-title>Pomegranate juice consumption increases GSH levels and reduces lipid and protein oxidation in human blood</article-title>. <source>Food Chem Toxicol</source>. <year>2014</year>;<volume>73</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.fct.2014.07.027">10.1016/j.fct.2014.07.027</ext-link></comment>
<pub-id pub-id-type="pmid">25092396</pub-id></mixed-citation></ref><ref id="pone.0160305.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Meltzer</surname><given-names>DE</given-names></name>. <article-title>Age dependence of Olympic Weightlifting ability</article-title>. <source>Med Sci Sports Exerc</source>. <year>1994</year>; <volume>26</volume>: <fpage>1053</fpage>&#x02013;<lpage>1067</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1249/00005768-199408000-00019">10.1249/00005768-199408000-00019</ext-link></comment>
<pub-id pub-id-type="pmid">7968424</pub-id></mixed-citation></ref><ref id="pone.0160305.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Bird</surname><given-names>SP</given-names></name>, <name><surname>Tarpenning</surname><given-names>KM</given-names></name>, <name><surname>Marino</surname><given-names>FE</given-names></name>. <article-title>Designing resistance training programmes to enhance muscular fitness. A review of the acute programme variables</article-title>. <source>Sports Med</source>. <year>2005</year>; <volume>35</volume>: <fpage>841</fpage>&#x02013;<lpage>851</lpage>
<pub-id pub-id-type="pmid">16180944</pub-id></mixed-citation></ref><ref id="pone.0160305.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Newham</surname><given-names>DJ</given-names></name>, <name><surname>Mills</surname><given-names>KR</given-names></name>, <name><surname>Quigley</surname><given-names>BM</given-names></name>, <name><surname>Edwards</surname><given-names>RH</given-names></name>. <article-title>Pain and fatigue after concentric and eccentric muscle contractions</article-title>. <source>Clin Sci</source>. <year>1983</year>; <volume>64</volume>: <fpage>55</fpage>&#x02013;<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1042/cs0640055">10.1042/cs0640055</ext-link></comment>
<pub-id pub-id-type="pmid">6822050</pub-id></mixed-citation></ref><ref id="pone.0160305.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Chtourou</surname><given-names>M</given-names></name>, <name><surname>Gargouri</surname><given-names>B</given-names></name>, <name><surname>Jaber</surname><given-names>H</given-names></name>, <name><surname>Bouaziz</surname><given-names>M</given-names></name>. <article-title>Comparative Study of olive quality from Chemlali Sfax Arbequina cultivated in Tunisia</article-title>. <source>Eur J Lipid Sci</source>. <year>2013</year>; <volume>115</volume>: <fpage>631</fpage>&#x02013;<lpage>640</lpage>.</mixed-citation></ref><ref id="pone.0160305.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Gargouri</surname><given-names>B</given-names></name>, <name><surname>Ammar</surname><given-names>S</given-names></name>, <name><surname>Zribi</surname><given-names>A</given-names></name>, <name><surname>Ben Mansour</surname><given-names>A</given-names></name>, <name><surname>Bouaziz</surname><given-names>M</given-names></name>. <article-title>Effect of growing region on quality characteristics and phenolic compounds of chemlali extra-virgin olive oils</article-title>. <source>Acta Physiol Plant</source>. <year>2013</year>; <volume>35</volume>: <fpage>2801</fpage>&#x02013;<lpage>2812</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11738-013-1312-z">10.1007/s11738-013-1312-z</ext-link></comment></mixed-citation></ref><ref id="pone.0160305.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Dridi-Gargouri</surname><given-names>O</given-names></name>, <name><surname>Kallel-Trabelsi</surname><given-names>S</given-names></name>, <name><surname>Bouaziz</surname><given-names>M</given-names></name>, <name><surname>Abdelh&#x000e8;di</surname><given-names>R</given-names></name>. <article-title>Synthesis of 3-O-methylgallic acid a powerful antioxidant by electrochemical conversion of syringic acid</article-title>. <source>Biochim Biophys Acta</source>. <year>2013</year>; <fpage>3643</fpage>&#x02013;<lpage>3649</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbagen.2013.02.012">10.1016/j.bbagen.2013.02.012</ext-link></comment>
<pub-id pub-id-type="pmid">23434437</pub-id></mixed-citation></ref><ref id="pone.0160305.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Storey</surname><given-names>A</given-names></name>, <name><surname>Smith</surname><given-names>HK</given-names></name>. <article-title>Unique aspects of competitive weightlifting: performance, training and physiology</article-title>. <source>Sports Med</source>. <year>2012</year>; <volume>42</volume>(<issue>9</issue>):<fpage>769</fpage>&#x02013;<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2165/11633000-000000000-00000">10.2165/11633000-000000000-00000</ext-link></comment>
<pub-id pub-id-type="pmid">22873835</pub-id></mixed-citation></ref><ref id="pone.0160305.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Cheung</surname><given-names>K</given-names></name>, <name><surname>Hume</surname><given-names>P</given-names></name>, <name><surname>Maxwell</surname><given-names>L</given-names></name>. <article-title>Delayed onset muscle soreness: treatment strategies and performance factors</article-title>. <source>Sports Med</source>. <year>2003</year>; <volume>33</volume>(<issue>2</issue>):<fpage>145</fpage>&#x02013;<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2165/00007256-200333020-00005">10.2165/00007256-200333020-00005</ext-link></comment>
<pub-id pub-id-type="pmid">12617692</pub-id></mixed-citation></ref><ref id="pone.0160305.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Beaton</surname><given-names>LJ</given-names></name>, <name><surname>Allan</surname><given-names>DA</given-names></name>, <name><surname>Tarnopolsky</surname><given-names>MA</given-names></name>, <name><surname>Tiidus</surname><given-names>PM</given-names></name>, <name><surname>Phillips</surname><given-names>SM</given-names></name>. <article-title>Contraction-induced muscle damage is unaffected by vitamin E supplementation</article-title>. <source>Med Sci Sports Exerc</source>. <year>2002</year>; <volume>34</volume>(<issue>5</issue>): <fpage>798</fpage>&#x02013;<lpage>805</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/00005768-200205000-00012">10.1097/00005768-200205000-00012</ext-link></comment>
<pub-id pub-id-type="pmid">11984298</pub-id></mixed-citation></ref><ref id="pone.0160305.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Close</surname><given-names>GL</given-names></name>, <name><surname>Ashton</surname><given-names>T</given-names></name>, <name><surname>Cable</surname><given-names>T</given-names></name>, <name><surname>Doran</surname><given-names>D</given-names></name>, <name><surname>Holloway</surname><given-names>C</given-names></name>, <name><surname>McArdle</surname><given-names>F</given-names></name>
<etal>et al</etal>
<article-title>Ascorbic acid supplementation does not attenuate post-exercise muscle soreness following muscle-damaging exercise but may delay the recovery process</article-title>. <source>Br J Nutr</source>. <year>2006</year>; <volume>95</volume>(<issue>5</issue>): <fpage>976</fpage>&#x02013;<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1079/bjn20061732">10.1079/bjn20061732</ext-link></comment>
<pub-id pub-id-type="pmid">16611389</pub-id></mixed-citation></ref><ref id="pone.0160305.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Donnelly</surname><given-names>AE</given-names></name>, <name><surname>McCormick</surname><given-names>K</given-names></name>, <name><surname>Maughan</surname><given-names>RJ</given-names></name>, <name><surname>Whiting</surname><given-names>PH</given-names></name>, <name><surname>Clarkson</surname><given-names>PM</given-names></name>. <article-title>Effects of a non-steroidal anti-inflammatory drug on delayed onset muscle soreness and indices of damage</article-title>. <source>Br J Sports Med</source>. <year>1988</year>; <volume>22</volume>(<issue>1</issue>): <fpage>35</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bjsm.22.1.35">10.1136/bjsm.22.1.35</ext-link></comment>
<pub-id pub-id-type="pmid">3370401</pub-id></mixed-citation></ref><ref id="pone.0160305.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Goldfarb</surname><given-names>AH</given-names></name>, <name><surname>Bloomer</surname><given-names>RJ</given-names></name>, <name><surname>McKenzie</surname><given-names>MJ</given-names></name>. <article-title>Combined antioxidant treatment effects on blood oxidative stress after eccentric exercise</article-title>. <source>Med Sci Sports Exerc</source>. <year>2005</year>; <volume>37</volume>(<issue>2</issue>): <fpage>234</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1249/01.mss.0000152887.87785.be">10.1249/01.mss.0000152887.87785.be</ext-link></comment>
<pub-id pub-id-type="pmid">15692318</pub-id></mixed-citation></ref><ref id="pone.0160305.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Phillips</surname><given-names>T</given-names></name>, <name><surname>Childs</surname><given-names>AC</given-names></name>, <name><surname>Dreon</surname><given-names>DM</given-names></name>, <name><surname>Phinney</surname><given-names>S</given-names></name>, <name><surname>Leeuwenburgh</surname><given-names>C</given-names></name>. <article-title>A dietary supplement attenuates IL-6 and CRP after eccentric exercise in untrained males</article-title>. <source>Med Sci Sports Exerc</source>. <year>2003</year>; <volume>35</volume>(<issue>12</issue>): <fpage>2032</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1249/01.MSS.0000099112.32342.10">10.1249/01.MSS.0000099112.32342.10</ext-link></comment>
<pub-id pub-id-type="pmid">14652498</pub-id></mixed-citation></ref><ref id="pone.0160305.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Wong</surname><given-names>EY</given-names></name>. <article-title>Why does my patient have thrombocytopenia?</article-title>
<source>Hematol Oncol Clin N Am</source>. <year>2012</year>; <volume>26</volume>: <fpage>231</fpage>&#x02013;<lpage>252</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.hoc.2012.02.006">10.1016/j.hoc.2012.02.006</ext-link></comment>
<pub-id pub-id-type="pmid">22463825</pub-id></mixed-citation></ref><ref id="pone.0160305.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Cudney</surname><given-names>LE</given-names></name>, <name><surname>Sassi</surname><given-names>RB</given-names></name>, <name><surname>Behr</surname><given-names>GA</given-names></name>, <name><surname>Streiner</surname><given-names>DL</given-names></name>, <name><surname>Minuzzi</surname><given-names>L</given-names></name>, <name><surname>Moreira</surname><given-names>JC</given-names></name>
<etal>et al</etal>
<article-title>Alterations in circadian rhythms are associated with increased lipid peroxidation in females with bipolar disorder</article-title>. <source>Int J Neuropsychopharmacol</source>. <year>2014</year>;<volume>17</volume>(<issue>5</issue>): <fpage>715</fpage>&#x02013;<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1017/S1461145713001740">10.1017/S1461145713001740</ext-link></comment>
<pub-id pub-id-type="pmid">24438530</pub-id></mixed-citation></ref><ref id="pone.0160305.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Tidball</surname><given-names>JG</given-names></name>. <article-title>Mechanisms of muscle injury, repair, and regeneration</article-title>. <source>Compr Physiol</source>. <year>2011</year>; <volume>1</volume>(<issue>4</issue>):<fpage>2029</fpage>&#x02013;<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/cphy.c100092">10.1002/cphy.c100092</ext-link></comment>
<pub-id pub-id-type="pmid">23733696</pub-id></mixed-citation></ref><ref id="pone.0160305.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Nosaka</surname><given-names>K</given-names></name>, <name><surname>Sakamoto</surname><given-names>K</given-names></name>, <name><surname>Newton</surname><given-names>M</given-names></name>, <name><surname>Sacco</surname><given-names>P</given-names></name>. <article-title>How long does the protective effect on eccentric exercise-induced muscle damage last?</article-title>
<source>Med Sci Sports Exerc</source>. <year>2001</year>
<month>9</month>; <volume>33</volume>(<issue>9</issue>):<fpage>1490</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/00005768-200109000-00011">10.1097/00005768-200109000-00011</ext-link></comment>
<pub-id pub-id-type="pmid">11528337</pub-id></mixed-citation></ref></ref-list></back></article>